Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

NRDY

Nerdy Inc

Feb 17 • 10:17AM ET

0.9800

-0.0200 -2.00 %

Technology • Software - Application • USA • NYSE

Peers: COUR CHGG LRN PRDO THRY LOPE APEI EDU UTI ATAI

| Held by: VTI IWM VXF IWO VTWO IWC VTWG BYOB RSSL MSSM

Index	RUT	P/E	-	EPS (ttm)	-0.34	Insider Own	69.87%	Shs Outstand	122.37M	Perf Week	-2.00%
Market Cap	183.58M	Forward P/E	-	EPS next Y	-0.06	Insider Trans	3.49%	Shs Float	37.04M	Perf Month	-5.77%
Enterprise Value	163.66M	PEG	-	EPS next Q	-0.03	Inst Own	15.33%	Short Float	20.03%	Perf Quarter	10.65%
Income	-40.83M	P/S	1.03	EPS this Y	4.35%	Inst Trans	-4.85%	Short Ratio	6.26	Perf Half Y	-22.83%
Sales	177.87M	P/B	4.94	EPS next Y	73.83%	ROA	-46.09%	Short Interest	7.42M	Perf YTD	-5.77%
Book/sh	0.20	P/C	5.61	EPS next 5Y	-	ROE	-120.79%	52W High	2.02 -51.49%	Perf Year	-49.74%
Cash/sh	0.17	P/FCF	-	EPS past 3/5Y	-99.95% -317.67%	ROIC	-168.20%	52W Low	0.77 27.27%	Perf 3Y	-65.25%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	10.59% -	Gross Margin	61.52%	Volatility	5.51% 6.29%	Perf 5Y	-91.27%
Dividend TTM	-	EV/Sales	0.92	EPS Y/Y TTM	0.87%	Oper. Margin	-36.13%	ATR (14)	0.06	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.43	Sales Y/Y TTM	-9.86%	Profit Margin	-22.95%	RSI (14)	44.06	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.43	EPS Q/Q	28.06%	SMA20	-4.36%	Beta	1.79	Target Price	2.19
Payout	-	Debt/Eq	0.00	Sales Q/Q	-1.36%	SMA50	-11.28%	Rel Volume	0.50	Prev Close	1.00
Employees	600	LT Debt/Eq	0.00	Earnings	Feb 26 AMC	SMA200	-25.64%	Avg Volume	1.18M	Price	0.98
IPO	Nov 27, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	20.63% -4.54%	Trades		Volume	96,777	Change	-2.00%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-11-24	Downgrade	JP Morgan	Neutral → Underweight
Nov-08-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Nov-08-24	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$6 → $1
Aug-09-24	Downgrade	Raymond James	Outperform → Mkt Perform
Aug-09-24	Downgrade	Northland Capital	Outperform → Market Perform
Aug-09-24	Downgrade	JP Morgan	Overweight → Neutral
Aug-09-24	Downgrade	Canaccord Genuity	Buy → Hold	$5 → $3
Mar-11-24	Resumed	JP Morgan	Overweight	$5
Oct-09-23	Resumed	Barclays	Equal Weight	$5
Aug-28-23	Resumed	Raymond James	Outperform	$5.50
May-17-22	Downgrade	Goldman	Buy → Neutral	$8 → $3
Mar-30-22	Initiated	Cantor Fitzgerald	Overweight	$7
Mar-01-22	Reiterated	Needham	Buy	$13 → $8
Jan-07-22	Initiated	Goldman	Buy	$8
Nov-12-21	Initiated	JP Morgan	Overweight	$12
Oct-18-21	Initiated	Raymond James	Outperform	$13
Oct-18-21	Initiated	Needham	Buy	$13
Oct-18-21	Initiated	Barclays	Equal Weight	$9
Oct-15-21	Initiated	JMP Securities	Mkt Outperform	$13
Oct-04-21	Initiated	Canaccord Genuity	Buy	$14

Show Previous Ratings

Feb-05-26 04:01PM	Nerdy to Announce Fourth Quarter and Full Year 2025 Results on February 26, 2026 (Business Wire)
Jan-28-26 06:05PM	Adtalem Global Education (ATGE) Q2 Earnings and Revenues Top Estimates (Zacks)
Jan-26-26 10:50AM	Google Rolls Out Free SAT Practice Exams In Gemini: Stocks To Watch (Benzinga) -7.14%
Jan-06-26 04:01PM	Nerdy to Participate in Needham Growth Conference (Business Wire)
Jan-05-26 09:00AM	Nerdy Announces CEO Chuck Cohn Purchased $4.4 million or 3.5 million Shares of Nerdy Common Stock During the Fourth Quarter. Since Becoming a Public Company, Mr. Cohn has Purchased $81.0 million or 51.4 million Shares of Nerdy Common Stock. (Business Wire)
08:29AM	Loading…
Dec-15-25 08:29AM	Here are 5 School Stocks to Buy Before Moving Into 2026 (Zacks) -5.93%
Dec-03-25 09:51AM	Zacks Industry Outlook Highlights Grand Canyon Education, McGraw Hill, Adtalem Global Education, Perdoceo Education and Nerdy (Zacks) +9.17%
Dec-01-25 11:30AM	5 School Stocks Leveraging AI, Digital Learning & Healthcare Shortages (Zacks) -8.21%
Nov-13-25 01:38PM	Cantor Lowers Nerdy Price Target to $1.00, Maintains Neutral (Insider Monkey)
12:00PM	Nerdy (NRDY) Upgraded to Buy: Here's What You Should Know (Zacks)
Nov-07-25 12:14AM	Nerdy Inc (NRDY) Q3 2025 Earnings Call Highlights: AI-Driven Innovations and Strategic ... (GuruFocus.com) -7.97%
Nov-06-25 05:50PM	Nerdy Inc. (NRDY) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Nerdy Announces Third Quarter 2025 Financial Results (Business Wire)
Nov-05-25 08:00AM	Nerdy Inc (NRDY) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-30-25 04:10PM	Nerdy to Announce Third Quarter 2025 Results on November 6, 2025 (Business Wire)
07:00AM	Loading…
Oct-01-25 07:00AM	Varsity Tutors Introduces New Live+AI Tools and Capabilities That Teachers and School Administrators Can Use to Support Student Learning (Business Wire)
Sep-27-25 06:45AM	10 Hidden-Gem AI Stocks to Buy Right Now (Motley Fool)
Aug-26-25 06:46PM	Nerdy Appoints John Paszterko as Chief Operating Officer (Business Wire)
Aug-08-25 03:44AM	Nerdy Inc (NRDY) Q2 2025 Earnings Call Highlights: A Return to Growth and AI Innovations Propel ... (GuruFocus.com) -14.67%
Aug-07-25 05:25PM	Nerdy Inc. (NRDY) Reports Q2 Loss, Lags Revenue Estimates (Zacks) +7.14%
04:01PM	Nerdy Announces Second Quarter 2025 Financial Results (Business Wire)
Aug-06-25 05:55PM	Grand Canyon Education (LOPE) Q2 Earnings and Revenues Top Estimates (Zacks)
Jul-17-25 04:01PM	Nerdy to Announce Second Quarter 2025 Results on August 7, 2025 (Business Wire)
Jun-30-25 01:00PM	Varsity Tutors Signs White House Pledge to Advance AI Education for Americas Youth (Business Wire)
May-23-25 12:00PM	All You Need to Know About Nerdy (NRDY) Rating Upgrade to Buy (Zacks)
May-09-25 03:52AM	Nerdy Inc (NRDY) Q1 2025 Earnings Call Highlights: Surpassing Revenue Expectations Amidst ... (GuruFocus.com) -6.13%
May-08-25 05:15PM	Nerdy Inc. (NRDY) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Nerdy Announces First Quarter 2025 Financial Results (Business Wire)
May-07-25 11:19AM	Earnings To Watch: Nerdy Inc (NRDY) Reports Q1 2025 Results (GuruFocus.com)
Apr-29-25 05:26PM	Varsity Tutors Launches Live + AI Platform for Schools, Delivering Next-Generation Tutoring & Teacher Support System (Business Wire)
09:40AM	Loading…
Apr-25-25 09:40AM	Are Consumer Discretionary Stocks Lagging Nerdy (NRDY) This Year? (Zacks)
Apr-24-25 04:01PM	Nerdy to Announce First Quarter 2025 Results on May 8, 2025 (Business Wire)
Mar-26-25 11:24AM	Is Nerdy Inc. (NYSE:NRDY) the Most Popular AI Penny Stock to Buy Under $5? (InsiderMonkey)
Mar-25-25 09:40AM	Is Nerdy (NRDY) Stock Outpacing Its Consumer Discretionary Peers This Year? (Zacks)
Feb-27-25 04:01PM	Nerdy Announces Fourth Quarter 2024 Financial Results (Business Wire)
Feb-06-25 04:01PM	Nerdy to Announce Fourth Quarter and Full Year 2024 Results on February 27, 2025 (Business Wire)
Jan-30-25 07:00AM	Preble Shawnee Local School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Jan-27-25 07:00AM	Buckeye Valley Local School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Jan-15-25 07:00AM	Prodos Academy of Education and Sport Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire) +7.69%
Jan-06-25 07:00AM	Winton Woods City School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire) +19.02%
Dec-18-24 07:00AM	Manassas City Public Schools Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire) -7.57%
Dec-17-24 07:00AM	Clover School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Dec-16-24 07:00AM	Iron County School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire) +9.20%
Dec-12-24 07:00AM	Parma City Schools Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Dec-10-24 07:00AM	Indian Hill Exempted Village School District Announces Partnership With Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Dec-03-24 09:00AM	Nerdy Regains Compliance with NYSE Continued Listing Standard (Business Wire)
07:00AM	Oak Hills Local School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Nov-12-24 05:36PM	Nerdy Announces Receipt of Notice From NYSE (Business Wire) -8.97%
Nov-07-24 04:01PM	Nerdy Announces Third Quarter 2024 Financial Results (Business Wire) -7.28%
Nov-04-24 07:00AM	Forest Charter School Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire) +6.84%
Oct-24-24 04:01PM	Nerdy to Announce Third Quarter 2024 Results on November 7, 2024 (Business Wire)
Oct-23-24 07:00AM	Harbor Science and Arts Charter School Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire) -5.93%
Oct-21-24 07:00AM	Northpoint Charter School Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Oct-10-24 07:00AM	McAlester Public Schools Announces Partnership With Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Oct-08-24 07:00AM	Harding Charter Preparatory School District Announces Partnership With Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Oct-04-24 07:00AM	Digital Ready Announces Partnership With Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for Students (Business Wire)
Sep-30-24 07:00AM	Mid-America Technology Center Announces Partnership With Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Sep-17-24 07:00AM	North Hills School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Sep-11-24 07:00AM	The Woodbury Leadership Academy Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Sep-09-24 07:00AM	Velma-Alma School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Sep-05-24 07:00AM	Estancia Valley Classical Academy Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Sep-03-24 07:00AM	The NET Charter High School Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire) -9.16%
Aug-28-24 07:00AM	St. Mary's School Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire) -5.61%
Aug-26-24 07:00AM	Wapakoneta City Schools Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Aug-21-24 07:00AM	The Township of Union Public Schools Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Aug-19-24 07:00AM	Johnson County Schools Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire) +13.09%
Aug-15-24 08:41PM	Nerdy, Inc. (NRDY) Analysis: Evaluating Growth and Investment Potential Among Top Technology Penny Stocks (Insider Monkey) +8.51%
Aug-08-24 04:01PM	Nerdy Announces Second Quarter 2024 Financial Results (Business Wire) +8.16% -48.06%
Aug-07-24 07:00AM	Frontier Schools Announce Partnership With Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire) -6.96%
Jul-30-24 07:00AM	West Ada School District Announces Partnership With Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students (Business Wire)
Jul-25-24 04:01PM	Nerdy to Announce Second Quarter 2024 Results on August 8, 2024 (Business Wire)
Jul-16-24 11:32AM	Nerdy (NRDY) Partners With Clarendon County School District (Zacks) +7.06%
07:30AM	3 Hidden AI Stocks That Could Outperform Nvidia (InvestorPlace)
Jul-15-24 10:00AM	3 Ultra-Speculative Stocks for Thrill-Seeking Traders (InvestorPlace)
07:00AM	Clarendon County School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students (Business Wire)
Jul-11-24 07:00AM	Ulysses USD 214 Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students (Business Wire) +9.68%
Jul-09-24 07:00AM	Hamtramck Public Schools Announce Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students (Business Wire)
Jul-04-24 01:07PM	3 Small-Cap Stocks Insiders Are Buying Hand Over Fist (InvestorPlace)
Jun-25-24 11:41PM	Nerdy Inc. (NRDY): Do Analysts See This AI Stock As a Promising Investment? (Insider Monkey)
Jun-11-24 06:30AM	3 Penny Stocks With the Power to 10X Your $1k Investment: June Edition (InvestorPlace) +10.76%
Jun-06-24 07:00AM	Western Michigan Christian High School and Middle School Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students (Business Wire)
Jun-01-24 04:11PM	11 Best AI Penny Stocks to Invest in Now (Insider Monkey)
May-30-24 12:28PM	Nerdy's (NRDY) Online Tuitions Open for Trinity Lutheran School (Zacks)
May-29-24 07:00AM	Trinity Lutheran School Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students (Business Wire)
May-17-24 07:52AM	3 Explosive Penny Stocks to Buy for 10X Returns in 2 Years (InvestorPlace)
May-10-24 07:00AM	Grayville Community School District 1 Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students (Business Wire) -8.19%
May-09-24 04:05PM	Nerdy to Participate in J.P. Morgan Conference (Business Wire)
May-08-24 07:00AM	Gateway Regional School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students (Business Wire) -8.68%
04:20AM	Nerdy Inc (NRDY) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic Expansions (GuruFocus.com)
May-07-24 10:55PM	NRDY Stock Earnings: Nerdy Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:01PM	Nerdy Announces First Quarter 2024 Financial Results (Business Wire)
May-06-24 07:00AM	Birdville Independent School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students (Business Wire)
May-03-24 07:00AM	Eagle Mountain-Saginaw Independent School District Selects Varsity Tutors for Schools to Provide Students with Additional Learning Resources (Business Wire)
May-02-24 04:01PM	Nerdy to Participate in Needham Conference (Business Wire)
07:00AM	Franklin County School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students (Business Wire)
May-01-24 06:01AM	3 Stocks Poised to Profit from the Rise of Artificial Intelligence (InvestorPlace)
Apr-30-24 07:00AM	Cleveland School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students (Business Wire)
Apr-23-24 04:01PM	Nerdy to Announce First Quarter 2024 Results on May 7, 2024 (Business Wire)
Apr-19-24 07:00AM	Gateway Science Academy Selects Varsity Tutors for Schools to Provide Students with Additional Learning Resources (Business Wire)
Apr-16-24 07:00AM	Dent-Phelps R-III School District Selects Varsity Tutors for Schools to Provide Students With Additional Learning Resources (Business Wire)

Nerdy, Inc. engages in the business of operating a platform for live online learning. The firm is also involved in providing a purpose-built proprietary platform that leverages technology including artificial intelligence, to connect students, users, parents, guardians, and purchasers of all ages to tutors, instructors, subject matter experts, educators, and other professionals delivering superior value on both sides of the network. The company was founded by Charles K. Cohn in October 2007 and is headquartered in St. Louis, MO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Paszterko John Andrew	Chief Operating Officer	Jan 16 '26	Sale	1.01	18,457	18,642	581,543	Jan 20 06:56 PM
Swenson Christopher C.	Chief Legal Officer	Dec 22 '25	Sale	1.33	35,000	46,550	1,455,383	Dec 29 04:23 PM
Christopher Swenson	Chief Legal Officer	Dec 22 '25	Proposed Sale	1.31	35,000	45,761		Dec 22 04:32 PM
Pello Jason H.	Chief Financial Officer	Dec 16 '25	Sale	1.20	32,006	38,407	1,696,049	Dec 18 04:22 PM
Swenson Christopher C.	Chief Legal Officer	Dec 16 '25	Sale	1.20	19,204	23,045	1,490,383	Dec 18 04:22 PM
Cohn Charles K.	Chief Executive Officer	Dec 16 '25	Buy	1.22	197,242	240,635	32,867,174	Dec 18 09:04 AM
Cohn Charles K.	Chief Executive Officer	Dec 15 '25	Buy	1.36	174,076	236,743	32,669,932	Dec 17 09:15 AM
Cohn Charles K.	Chief Executive Officer	Dec 12 '25	Buy	1.38	180,353	248,887	32,495,856	Dec 16 08:51 AM
Cohn Charles K.	Chief Executive Officer	Dec 11 '25	Buy	1.38	180,000	248,400	32,315,503	Dec 15 09:07 AM
Pello Jason H.	Chief Financial Officer	Dec 10 '25	Sale	1.39	75,000	104,250	1,728,055	Dec 12 05:06 PM
Cohn Charles K.	Chief Executive Officer	Dec 10 '25	Buy	1.40	174,947	244,926	32,135,503	Dec 12 08:54 AM
Cohn Charles K.	Chief Executive Officer	Dec 09 '25	Buy	1.44	176,215	253,750	31,960,556	Dec 11 08:37 AM
Pello Jason H.	Officer	Dec 10 '25	Proposed Sale	1.44	75,000	108,000		Dec 10 10:23 AM
Cohn Charles K.	Chief Executive Officer	Dec 08 '25	Buy	1.33	184,491	245,373	31,784,341	Dec 10 07:32 AM
Cohn Charles K.	Chief Executive Officer	Dec 05 '25	Buy	1.40	177,969	249,157	31,599,850	Dec 09 06:58 AM
Cohn Charles K.	Chief Executive Officer	Dec 04 '25	Buy	1.37	186,930	256,094	31,421,881	Dec 08 09:21 AM
Cohn Charles K.	Chief Executive Officer	Dec 03 '25	Buy	1.31	181,672	238,857	31,234,951	Dec 05 08:34 AM
Cohn Charles K.	Chief Executive Officer	Dec 02 '25	Buy	1.26	198,100	249,606	1,278,512	Dec 04 06:33 AM
Cohn Charles K.	Chief Executive Officer	Dec 01 '25	Buy	1.32	189,000	249,480	1,080,412	Dec 03 10:04 AM
Cohn Charles K.	Chief Executive Officer	Nov 28 '25	Buy	1.32	80,708	106,535	891,412	Dec 02 08:31 AM
Cohn Charles K.	Chief Executive Officer	Nov 26 '25	Buy	1.25	144,783	180,979	1,540,307	Dec 01 07:12 AM
Cohn Charles K.	Chief Executive Officer	Nov 25 '25	Buy	1.16	119,242	138,321	1,395,524	Nov 28 08:58 AM
Cohn Charles K.	Chief Executive Officer	Nov 24 '25	Buy	1.05	238,749	250,686	1,276,282	Nov 26 09:25 AM
Cohn Charles K.	Chief Executive Officer	Nov 21 '25	Buy	1.06	257,210	273,343	31,053,279	Nov 25 08:48 AM
Cohn Charles K.	Chief Executive Officer	Nov 19 '25	Buy	0.91	270,578	246,226	30,779,769	Nov 21 08:13 AM
Pello Jason H.	Chief Financial Officer	Nov 17 '25	Sale	0.84	43,969	36,934	1,803,055	Nov 18 08:12 PM
Swenson Christopher C.	Chief Legal Officer	Nov 17 '25	Sale	0.84	28,810	24,200	1,509,587	Nov 18 08:11 PM
Mrva Gregory	Director	Nov 13 '25	Sale	0.89	25,000	22,250	710,991	Nov 14 04:03 PM
Mrva Gregory	Director	Nov 14 '25	Sale	0.85	25,000	21,250	685,991	Nov 14 04:03 PM
Mrva Gregory	Director	Nov 13 '25	Proposed Sale	0.87	50,000	43,500		Nov 13 04:44 PM
Swenson Christopher C.	Chief Legal Officer	Sep 16 '25	Sale	1.27	18,428	23,404	1,538,397	Sep 18 05:44 PM
Pello Jason H.	Chief Financial Officer	Sep 16 '25	Sale	1.27	30,714	39,007	1,847,024	Sep 18 05:43 PM
Blunt Abigail	Director	Aug 29 '25	Buy	1.36	25,000	34,000	226,000	Sep 03 09:00 AM
Swenson Christopher C.	Chief Legal Officer	Aug 18 '25	Sale	1.27	37,845	48,063	1,556,825	Aug 20 05:43 PM
Pello Jason H.	Chief Financial Officer	Aug 18 '25	Sale	1.27	52,866	67,140	1,877,738	Aug 20 05:42 PM
Pello Jason H.	Chief Financial Officer	Jun 16 '25	Sale	1.61	29,530	47,543	1,930,604	Jun 18 04:43 PM
Swenson Christopher C.	Chief Legal Officer	Jun 16 '25	Sale	1.61	17,718	28,526	1,594,670	Jun 18 04:43 PM
Blunt Abigail	Director	May 23 '25	Buy	1.60	7,370	11,792	196,000	May 28 04:52 PM
Blunt Abigail	Director	May 27 '25	Buy	1.62	5,000	8,100	201,000	May 28 04:52 PM
Pello Jason H.	Chief Financial Officer	May 16 '25	Sale	1.67	76,794	128,246	1,960,134	May 20 05:43 PM
Swenson Christopher C.	Chief Legal Officer	May 16 '25	Sale	1.67	53,514	89,368	1,612,388	May 20 05:42 PM
Pello Jason H.	Chief Financial Officer	Mar 17 '25	Sale	1.54	31,877	49,091	2,036,928	Mar 19 06:47 PM
Swenson Christopher C.	Chief Legal Officer	Mar 17 '25	Sale	1.54	19,126	29,454	1,665,902	Mar 19 06:46 PM
Pello Jason H.	Chief Financial Officer	Mar 12 '25	Sale	1.51	75,000	113,250	2,068,805	Mar 14 05:02 PM
Blunt Abigail	Director	Mar 10 '25	Buy	1.51	14,530	21,940	188,630	Mar 12 04:37 PM
Pello Jason H.	Officer	Mar 12 '25	Proposed Sale	1.53	75,000	114,810		Mar 12 10:14 AM
Pello Jason H.	Chief Financial Officer	Feb 18 '25	Sale	1.80	81,381	146,486	2,143,805	Feb 20 06:08 PM
Swenson Christopher C.	Chief Legal Officer	Feb 18 '25	Sale	1.80	58,220	104,796	1,685,028	Feb 20 06:07 PM

Open in Screener

DMLP

Dorchester Minerals LP

Feb 17 • 10:18AM ET

25.25

-0.23 -0.92 %

Energy • Oil & Gas E&P • USA • NASD

DMLP Dorchester Minerals LP daily Stock Chart

Peers: EPD OKE ENB MPLX TRP KMI PAA BEP WES ENLC

| Held by: INFL

Index	-	P/E	22.42	EPS (ttm)	1.13	Insider Own	11.47%	Shs Outstand	48.26M	Perf Week	1.30%
Market Cap	1.22B	Forward P/E	-	EPS next Y	-	Insider Trans	1.38%	Shs Float	42.72M	Perf Month	8.30%
Enterprise Value	1.17B	PEG	-	EPS next Q	-	Inst Own	23.16%	Short Float	1.37%	Perf Quarter	6.03%
Income	53.38M	P/S	8.08	EPS this Y	-	Inst Trans	2.49%	Short Ratio	3.02	Perf Half Y	2.12%
Sales	150.69M	P/B	3.72	EPS next Y	-	ROA	14.55%	Short Interest	0.58M	Perf YTD	12.90%
Book/sh	6.79	P/C	29.28	EPS next 5Y	-	ROE	14.72%	52W High	32.47 -22.25%	Perf Year	-20.96%
Cash/sh	0.86	P/FCF	9.39	EPS past 3/5Y	3.31% 7.37%	ROIC	16.26%	52W Low	20.85 21.08%	Perf 3Y	-14.77%
Dividend Est.	-	EV/EBITDA	9.63	Sales past 3/5Y	20.02% 15.44%	Gross Margin	45.59%	Volatility	2.36% 2.65%	Perf 5Y	78.28%
Dividend TTM	2.79 (11.06%)	EV/Sales	7.79	EPS Y/Y TTM	-59.55%	Oper. Margin	36.77%	ATR (14)	0.66	Perf 10Y	152.45%
Dividend Ex-Date	Feb 02, 2026	Quick Ratio	10.05	Sales Y/Y TTM	-12.51%	Profit Margin	35.42%	RSI (14)	59.85	Recom	-
Dividend Gr. 3/5Y	31.64% 11.67%	Current Ratio	10.05	EPS Q/Q	-74.18%	SMA20	2.06%	Beta	0.59	Target Price	-
Payout	163.47%	Debt/Eq	0.00	Sales Q/Q	-33.77%	SMA50	7.55%	Rel Volume	0.60	Prev Close	25.48
Employees	27	LT Debt/Eq	0.00	Earnings	-	SMA200	-0.16%	Avg Volume	193.57K	Price	25.25
IPO	Feb 03, 2003	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	19,463	Change	-0.92%

Jan-22-26 05:15PM	Dorchester Minerals, L.P. Announces Its Fourth Quarter Distribution (GlobeNewswire)
Dec-09-25 05:11PM	Dorchester Minerals, L.P. Announces the Retirement of Mr. William Casey McManemin from the Board of Managers; Appointments of Mr. Robert C. Vaughn as Interim Chairman and Mr. Albert G. Nance III to the Board of Managers (GlobeNewswire)
Nov-06-25 04:02PM	Dorchester Minerals, L.P. Announces Third Quarter Results (GlobeNewswire)
Nov-04-25 05:48PM	Dorchester Minerals, L.P. Announces the Passing of C.W. "Bill" Russell (GlobeNewswire)
Oct-23-25 04:45PM	Dorchester Minerals, L.P. Announces Its Third Quarter Distribution (GlobeNewswire)
09:50AM	Loading…
Oct-02-25 09:50AM	Why Goldman Sachs Is Betting More on Dorchester Minerals, L.P. (DMLP) (Insider Monkey)
Sep-02-25 05:16PM	Dorchester Minerals, L.P. Announces Acquisition of Mineral Interests (GlobeNewswire)
Aug-07-25 04:02PM	Dorchester Minerals, L.P. Announces Second Quarter Results (GlobeNewswire)
Jul-30-25 01:01AM	DMLP- A High-Yielding Energy Play Primed to Rally if Oil and Gas Prices Rise (MoneyShow)
Jul-25-25 09:45AM	Dividends Declared Week of July 21 (Hart Energy)
Jul-24-25 04:40PM	Dorchester Minerals, L.P. Announces Its Second Quarter Distribution (GlobeNewswire)
May-19-25 05:30PM	Dorchester Minerals, L.P. Announces Retirement and Appointment to the Board of Managers (GlobeNewswire)
May-08-25 12:39PM	Dorchester Minerals, L.P. Announces First Quarter Results (GlobeNewswire)
Apr-24-25 04:05PM	Dorchester Minerals, L.P. Announces Its First Quarter Distribution (GlobeNewswire)
Apr-22-25 06:09AM	Dorchester Minerals: Solid Business Model And Balance Sheet To Sustain Cash Distributions (Seeking Alpha)
05:22PM	Loading…
Feb-20-25 05:22PM	Dorchester Minerals, L.P. Announces 2024 Results (GlobeNewswire)
Jan-23-25 04:10PM	Dorchester Minerals, L.P. Announces Its Fourth Quarter Distribution (GlobeNewswire)
Dec-27-24 02:18PM	Range Resources Stock Gets RS Rating Lift (Investor's Business Daily)
Dec-15-24 03:00AM	Three Smaller Energy Stocks See Big Insider Buys (Barrons.com)
Oct-31-24 04:05PM	Dorchester Minerals, L.P. Announces Third Quarter Results (GlobeNewswire)
Oct-17-24 04:10PM	Dorchester Minerals, L.P. Announces Its Third Quarter Distribution (GlobeNewswire)
Oct-15-24 04:20PM	Dorchester Minerals, L.P. Announces Appointment of Manager to Board of Managers (GlobeNewswire)
Oct-11-24 07:03PM	Davidson Kempner Capital Management LP Acquires New Stake in Dorchester Minerals LP (GuruFocus.com)
Sep-30-24 04:15PM	Dorchester Minerals, L.P. Announces Two Acquisitions of Mineral, Royalty and Overriding Royalty Interests (GlobeNewswire)
Sep-16-24 08:30AM	Dorchester Minerals, L.P. Announces Two Agreements to Acquire Mineral, Royalty and Overriding Royalty Interests (GlobeNewswire)
Aug-01-24 04:05PM	Dorchester Minerals, L.P. Announces Second Quarter Results (GlobeNewswire)
Jul-18-24 04:19PM	Dorchester Minerals, L.P. Announces Its Second Quarter Distribution (GlobeNewswire)
May-02-24 10:54PM	DMLP Stock Earnings: Dorchester Minerals Reported Results for Q1 2024 (InvestorPlace) -6.93%
04:05PM	Dorchester Minerals, L.P. Announces First Quarter Results (GlobeNewswire)
Apr-18-24 04:01PM	Dorchester Minerals, L.P. Announces Its First Quarter Distribution (GlobeNewswire)
04:05PM	Loading…
Mar-28-24 04:05PM	Dorchester Minerals, L.P. Announces Acquisition of Mineral Interests (GlobeNewswire)
Mar-05-24 09:51AM	DMLP Stock Earnings: Dorchester Minerals Reported Results for Q4 2023 (InvestorPlace)
Feb-22-24 02:02PM	Dorchester Minerals, L.P. Announces 2023 Results (GlobeNewswire)
Jan-25-24 05:07AM	Dorchester Minerals LP's Dividend Analysis (GuruFocus.com)
Jan-18-24 02:35PM	Dorchester Minerals, L.P. Announces Its Fourth Quarter Distribution (GlobeNewswire)
Jan-12-24 03:47PM	Dorchester Minerals, L.P. Announces Appointment of Manager to Board of Managers (GlobeNewswire)
Jan-03-24 04:00PM	Dorchester Minerals, L.P. Announces Retirement of James E. Raley (GlobeNewswire)
Nov-14-23 05:03AM	Insider Buying: CFO Leslie Moriyama Acquires 8,013 Shares of Dorchester Minerals LP (DMLP) (GuruFocus.com)
Nov-07-23 02:20PM	Dorchester Minerals, L.P. Announces Consummation of Midland Basin Lease Transaction (GlobeNewswire)
Nov-02-23 03:50PM	Dorchester Minerals, L.P. Announces Third Quarter Results (GlobeNewswire)
Oct-27-23 07:09AM	Dorchester Minerals LP's Dividend Analysis (GuruFocus.com)
Oct-19-23 02:30PM	Dorchester Minerals, L.P. Announces Its Third Quarter Distribution (GlobeNewswire)
Sep-29-23 02:37PM	Dorchester Minerals, L.P. Completes Acquisition of Mineral and Royalty Interests (GlobeNewswire)
Aug-31-23 02:37PM	Dorchester Minerals, L.P. Completes Acquisition of Mineral and Royalty Interests (GlobeNewswire)
Aug-10-23 06:58AM	10 Energy Stocks with Insider Buying (Insider Monkey)
Aug-03-23 03:45PM	Dorchester Minerals, L.P. Announces Second Quarter Results (GlobeNewswire)
Jul-20-23 03:00PM	Dorchester Minerals, L.P. Announces Its Second Quarter Distribution (GlobeNewswire)
Jul-12-23 12:00PM	Dorchester Minerals, L.P. Completes Acquisition of Mineral and Royalty Interests (GlobeNewswire)
May-04-23 12:45PM	Dorchester Minerals, L.P. Announces First Quarter Results (GlobeNewswire)
Apr-20-23 02:38PM	Dorchester Minerals, L.P. Announces Its First Quarter Distribution and Investor Presentation (GlobeNewswire)
Feb-23-23 01:30PM	Dorchester Minerals, L.P. Announces 2022 Results (GlobeNewswire)
Jan-19-23 02:15PM	Dorchester Minerals, L.P. Announces Its Fourth Quarter Distribution (GlobeNewswire)
Dec-19-22 08:00PM	The Top 5 U.S. Oil And Gas Dividend Stocks For 2023 (Oilprice.com)
Nov-03-22 04:00PM	Dorchester Minerals, L.P. Announces Third Quarter Results (GlobeNewswire)
Oct-20-22 02:15PM	Dorchester Minerals, L.P. Announces Its Third Quarter Distribution (GlobeNewswire)
Oct-03-22 04:33PM	Dorchester Minerals, L.P. Announces Consummation of Midland Basin Lease Transaction (GlobeNewswire) +6.85%
Sep-30-22 12:00PM	Dorchester Minerals, L.P. Completes Acquisition of Mineral, Royalty and Overriding Royalty Interests (GlobeNewswire)
Sep-22-22 05:38PM	Dorchester Minerals, L.P. Announces Transitions and New Appointment (GlobeNewswire) -10.20%
Sep-19-22 09:00AM	Dorchester Minerals, L.P. Announces Acquisition of Mineral, Royalty and Overriding Royalty Interests (GlobeNewswire)
Sep-14-22 05:50PM	Dorchester Minerals, L.P. Announces 2021 Schedule K-3 Available (GlobeNewswire)
Sep-05-22 09:11AM	Top 10 Small Company Stocks You Should Own Now (Insider Monkey)
Aug-04-22 12:45PM	Dorchester Minerals, L.P. Announces Second Quarter Results (GlobeNewswire)
Jul-21-22 01:15PM	Dorchester Minerals, L.P. Announces Its Second Quarter Distribution (GlobeNewswire)
May-05-22 11:55AM	Dorchester Minerals, L.P. Announces First Quarter Results (GlobeNewswire)
Apr-21-22 01:00PM	Dorchester Minerals, L.P. Announces Its First Quarter Distribution (GlobeNewswire)
Mar-31-22 04:01PM	Dorchester Minerals, L.P. Completes Acquisition of Mineral and Royalty Interests (GlobeNewswire)
Mar-18-22 09:24AM	10 Best MLP Dividend Stocks To Buy (Insider Monkey)
Mar-02-22 04:15PM	Dorchester Minerals, L.P. Announces Acquisition of Mineral and Royalty Interests (GlobeNewswire)
Feb-24-22 04:30PM	Dorchester Minerals, L.P. Announces 2021 Results (GlobeNewswire)
Jan-20-22 01:15PM	Dorchester Minerals, L.P. Announces Its Fourth Quarter Distribution (GlobeNewswire)
Jan-05-22 02:20PM	Dorchester Minerals Stock Sees Composite Rating Improve To 96 (Investor's Business Daily)
Dec-31-21 04:05PM	Dorchester Minerals, L.P. Completes Acquisition of Mineral and Royalty Interests (GlobeNewswire)
Dec-24-21 12:38PM	Concorde Funds Inc Buys PIMCO Enhanced Short Maturity Active Exchange-Trad, JPMorgan ... (GuruFocus.com)
Dec-02-21 09:40AM	10 Dividend Stocks to Buy According to Murray Stahls Horizon Asset Management (Insider Monkey)
Nov-23-21 04:05PM	Dorchester Minerals, L.P. Announces Acquisition of Mineral and Royalty Interests (GlobeNewswire)
Nov-04-21 11:50AM	Dorchester Minerals, L.P. Announces Third Quarter Results (GlobeNewswire)
Oct-21-21 02:25PM	Dorchester Minerals, L.P. Announces Its Third Quarter Distribution (GlobeNewswire)
Sep-20-21 03:28PM	Dow Jones Dives 900 Points Amid China Fears; Nvidia Flashes Sell Signal; Tesla Crashes Lower (Investor's Business Daily)
Aug-05-21 12:45PM	Dorchester Minerals, L.P. Announces Second Quarter Results (GlobeNewswire)
Jul-23-21 06:46PM	Dorchester Minerals, L.P. Announces Its Second Quarter Distribution (GlobeNewswire)
Jul-21-21 10:22PM	Nautilus, Inc. (NLS) Fell Out Of Favor With Hedge Funds? (Insider Monkey)
Jun-30-21 02:50PM	Dorchester Minerals, L.P. Completes Acquisition of Royalty Properties (GlobeNewswire)
Jun-13-21 06:13PM	Should I Avoid Dorchester Minerals LP (DMLP)? (Insider Monkey)
May-06-21 01:25PM	Dorchester Minerals, L.P. Announces First Quarter Results and the Acquisition of Royalty Properties (GlobeNewswire)
Apr-22-21 02:30PM	Dorchester Minerals, L.P. Announces Its First Quarter Distribution (GlobeNewswire)
Feb-25-21 12:25PM	Dorchester Minerals, L.P. Announces 2020 Results (GlobeNewswire)
Jan-21-21 01:15PM	Dorchester Minerals, L.P. Announces Its Fourth Quarter Distribution (GlobeNewswire)
Dec-01-20 12:20PM	Is Dorchester Minerals (DMLP) A Good Stock To Buy Now? (Insider Monkey)
Nov-05-20 12:10PM	Dorchester Minerals, L.P. Announces Third Quarter Results (GlobeNewswire)
Oct-22-20 01:39PM	Dorchester Minerals, L.P. Announces Its Third Quarter Distribution (GlobeNewswire)
Aug-06-20 02:19PM	Dorchester Minerals, L.P. Announces Second Quarter Results (GlobeNewswire)
Jul-23-20 12:40PM	Dorchester Minerals, L.P. Announces Its Second Quarter Distribution (GlobeNewswire)
Jun-12-20 06:37PM	Dorchester Minerals LP (DMLP): Hedge Funds Nibbling (Insider Monkey)
May-07-20 03:50PM	Dorchester Minerals, L.P. Announces First Quarter Results (GlobeNewswire)
Apr-23-20 01:43PM	Dorchester Minerals, L.P. Announces Its First Quarter Distribution (GlobeNewswire)
Apr-03-20 07:50AM	Dorchester Minerals, L.P. Announces Change of Date and Time of Annual Meeting of Limited Partners and Change to Virtual Format (GlobeNewswire)
Feb-27-20 03:00PM	Dorchester Minerals, L.P. Announces 2019 Results (GlobeNewswire)
Jan-23-20 12:45PM	Dorchester Minerals, L.P. Announces Its Fourth Quarter Distribution (GlobeNewswire) -13.99%
Jan-13-20 02:44PM	4 Energy Stocks to Power the New Year (InvestorPlace)
Dec-17-19 04:39PM	Is Dorchester Minerals LP (DMLP) A Good Stock To Buy? (Insider Monkey)

Dorchester Minerals LP engages in the acquisition, ownership, and administration of royalty properties and net profits interests (NPI). The NPI represents a net profits overriding royalty interest burdening various properties owned by its operating partnership. Royalty properties consist of producing and nonproducing mineral, royalty, overriding royalty, net profits, and leasehold interests. The company was founded in 1982 and is headquartered in Dallas, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DORCHESTER MINERALS OPERATING	Entity Under Common Control	Feb 11 '26	Buy	25.29	10,000	252,900	45,017	Feb 13 03:39 PM
DORCHESTER MINERALS OPERATING	Entity Under Common Control	Feb 13 '26	Buy	25.29	5,000	126,450	55,017	Feb 13 03:39 PM
DORCHESTER MINERALS OPERATING	Entity Under Common Control	Feb 12 '26	Buy	25.08	5,000	125,400	50,017	Feb 13 03:39 PM
DORCHESTER MINERALS OPERATING	Entity Under Common Control	Dec 22 '25	Buy	22.30	10,000	222,994	35,017	Dec 23 11:13 AM
DORCHESTER MINERALS OPERATING	Entity Under Common Control	Dec 19 '25	Buy	22.23	5,000	111,130	25,017	Dec 23 11:13 AM
DORCHESTER MINERALS OPERATING	Entity Under Common Control	Dec 18 '25	Buy	22.28	15,729	350,422	20,017	Dec 19 03:20 PM
DORCHESTER MINERALS OPERATING	Entity Under Common Control	Dec 17 '25	Buy	22.19	4,271	94,794	4,288	Dec 19 03:20 PM
MORIYAMA LESLIE A	Chief Financial Officer	Dec 15 '25	Option Exercise	0.00	4,351	0	99,964	Dec 17 05:28 PM
EHRMAN BRADLEY J	Chief Executive Officer	Dec 15 '25	Option Exercise	0.00	4,727	0	34,437	Dec 17 05:25 PM
MORIYAMA LESLIE A	Chief Financial Officer	Dec 03 '25	Option Exercise	0.00	4,017	0	97,234	Dec 05 04:49 PM
EHRMAN BRADLEY J	Chief Executive Officer	Dec 03 '25	Option Exercise	0.00	4,810	0	31,459	Dec 05 04:46 PM
Box Frank Damon	Director	Dec 03 '25	Buy	21.96	5,000	109,825	9,000	Dec 03 05:38 PM
VAUGHN ROBERT C	Director	Nov 28 '25	Buy	21.36	195	4,165	20,547	Dec 02 05:10 PM
VAUGHN ROBERT C	Director	Nov 25 '25	Buy	21.41	4,615	98,800	20,352	Nov 28 09:08 AM
MORIYAMA LESLIE A	Chief Financial Officer	Nov 25 '25	Buy	21.50	3,041	65,382	83,673	Nov 28 09:04 AM
EHRMAN BRADLEY J	Chief Executive Officer	Nov 26 '25	Buy	21.60	2,487	53,719	121,197	Nov 26 02:55 PM
EHRMAN BRADLEY J	Chief Executive Officer	Nov 25 '25	Buy	21.26	1,000	21,260	118,710	Nov 26 02:55 PM
Box Frank Damon	Director	Sep 05 '25	Buy	25.57	4,000	102,276	4,000	Sep 08 01:36 PM
DORCHESTER MINERALS OPERATING	Entity Under Common Control	Apr 30 '25	Buy	28.76	10,000	287,600	58,017	May 01 04:19 PM
EHRMAN BRADLEY J	Chief Executive Officer	Mar 03 '25	Buy	29.80	3,356	100,009	117,710	Mar 04 08:40 PM

Open in Screener

GLSI

Greenwich LifeSciences Inc

Feb 17 • 10:18AM ET

24.77

-2.08 -7.75 %

Healthcare • Biotechnology • USA • NASD

GLSI Greenwich LifeSciences Inc daily Stock Chart

Peers: JNJ LLY MRNA AZN-D PFE REGN GSK BMY BNTX NVAX

| Held by: VTI IWM VXF IWO VTWO IWC VTWG RSSL RFLR VTHR

Index	RUT	P/E	-	EPS (ttm)	-1.46	Insider Own	52.61%	Shs Outstand	13.79M	Perf Week	-16.68%
Market Cap	343.17M	Forward P/E	-	EPS next Y	-1.34	Insider Trans	0.46%	Shs Float	6.57M	Perf Month	-8.90%
Enterprise Value	339.36M	PEG	-	EPS next Q	-0.32	Inst Own	9.49%	Short Float	20.07%	Perf Quarter	202.07%
Income	-19.48M	P/S	-	EPS this Y	-1.24%	Inst Trans	-4.69%	Short Ratio	2.49	Perf Half Y	103.53%
Sales	0.00M	P/B	156.39	EPS next Y	-9.80%	ROA	-404.39%	Short Interest	1.32M	Perf YTD	17.90%
Book/sh	0.16	P/C	90.07	EPS next 5Y	-	ROE	-543.43%	52W High	34.10 -27.36%	Perf Year	100.08%
Cash/sh	0.28	P/FCF	-	EPS past 3/5Y	-50.90% -32.98%	ROIC	-891.35%	52W Low	7.78 218.38%	Perf 3Y	49.67%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.66% 14.79%	Perf 5Y	-35.96%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-80.51%	Oper. Margin	-	ATR (14)	3.36	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.35	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	47.82	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.35	EPS Q/Q	-49.88%	SMA20	-9.84%	Beta	1.51	Target Price	47.50
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	14.64%	Rel Volume	0.62	Prev Close	26.85
Employees	8	LT Debt/Eq	0.00	Earnings	Nov 10	SMA200	90.06%	Avg Volume	529.19K	Price	24.77
IPO	Sep 25, 2020	Option/Short	No / Yes	EPS/Sales Surpr.	8.33% -	Trades		Volume	55,108	Change	-7.75%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-20-25	Initiated	Noble Capital Markets	Outperform	$45
Sep-01-21	Initiated	H.C. Wainwright	Buy	$78

Jan-30-26 10:36AM	$170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium (PR Newswire)
Jan-27-26 06:00AM	Greenwich LifeSciences Provides Update on FLAMINGO-01 Cash Burn Rate and Financing Strategy (GlobeNewswire) +9.62%
Jan-22-26 10:59AM	Greenwich LifeSciences Stock Jumps After FDA Update (Benzinga) +5.65%
06:00AM	Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01 (GlobeNewswire)
Jan-07-26 10:32AM	How $594B in Precision Tech is Cracking the Metastatic Cancer Code (PR Newswire) +21.68%
06:00AM	Loading…
Dec-29-25 06:00AM	Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026 (GlobeNewswire) +19.80%
Dec-22-25 06:00AM	Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy (GlobeNewswire)
Dec-15-25 06:00AM	Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01 (GlobeNewswire)
Dec-08-25 06:00AM	Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01 (GlobeNewswire) +7.49%
Dec-03-25 06:00AM	Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date (GlobeNewswire) +5.12%
Oct-09-25 06:00AM	Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial (GlobeNewswire)
Oct-02-25 06:00AM	Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium (GlobeNewswire) +5.34%
Sep-30-25 06:00AM	Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial (GlobeNewswire)
Sep-18-25 06:00AM	Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Ireland (GlobeNewswire)
Sep-10-25 06:00AM	Greenwich LifeSciences' GLSI-100 Granted US FDA Fast Track Designation (GlobeNewswire)
09:25AM	Loading…
Aug-20-25 09:25AM	Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences (GlobeNewswire)
Aug-19-25 06:00AM	Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team (GlobeNewswire)
Aug-13-25 06:00AM	Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania (GlobeNewswire)
Aug-11-25 06:00AM	Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events (GlobeNewswire)
Apr-03-25 08:00AM	Greenwich LifeSciences Provides Global Update on FLAMINGO-01 (GlobeNewswire)
Apr-02-25 06:00AM	Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial (GlobeNewswire)
Mar-27-25 06:00AM	Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026 (GlobeNewswire)
Mar-17-25 06:45AM	Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01 (GlobeNewswire)
Feb-10-25 06:00AM	Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01 (GlobeNewswire)
Jan-30-25 11:13AM	EMA approves addition of sites to Greenwich LifeSciences breast cancer trial (Clinical Trials Arena)
Jan-29-25 06:00AM	Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe (GlobeNewswire)
Jan-27-25 06:00AM	Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland (GlobeNewswire)
Jan-23-25 06:00AM	Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01 (GlobeNewswire)
Jan-22-25 06:00AM	Greenwich LifeSciences Provides Update on Commercial Manufacturing (GlobeNewswire)
Jan-14-25 06:15AM	Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01 (GlobeNewswire)
07:00AM	Loading…
Jan-13-25 07:00AM	Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France (GlobeNewswire)
Nov-26-24 06:00AM	Greenwich LifeSciences Partners with GIM in Italy (GlobeNewswire)
Nov-18-24 06:00AM	Greenwich LifeSciences Provides Update on Corporate Events (GlobeNewswire)
Aug-01-24 06:00AM	Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain (GlobeNewswire)
Jun-26-24 07:33AM	Greenwich LifeSciences Set to Join Russell 2000 Index Again (GlobeNewswire) +11.18%
Jun-17-24 09:00AM	Insider Buying: CEO and CFO Snehal Patel Acquires Shares of Greenwich LifeSciences Inc (GLSI) (GuruFocus.com) +18.16%
Jun-14-24 06:00AM	Greenwich LifeSciences Announces $2.5 Million Private Placement (GlobeNewswire)
May-20-24 09:53PM	GLSI Stock Earnings: Greenwich LifeSciences Beats EPS for Q1 2024 (InvestorPlace) -6.44%
Apr-15-24 10:53PM	GLSI Stock Earnings: Greenwich LifeSciences Misses EPS for Q4 2023 (InvestorPlace) -8.88%
Apr-10-24 03:30PM	Insiders are Piling into These 10 Healthcare Stocks in 2024 (Insider Monkey)
Mar-13-24 06:00AM	Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025 (GlobeNewswire)
Mar-12-24 06:00AM	Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe (GlobeNewswire) +8.20%
Mar-07-24 09:00AM	Greenwich LifeSciences Inc (GLSI) CEO and CFO, 10% Owner Snehal Patel Acquires Additional Shares (GuruFocus.com) +19.93%
Feb-27-24 06:00AM	Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries (GlobeNewswire)
Feb-22-24 06:00AM	Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators (GlobeNewswire)
Feb-14-24 06:00AM	Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01 (GlobeNewswire) +22.74%
Nov-21-23 06:00AM	Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024 (GlobeNewswire)
Sep-13-23 05:02PM	Insider Buying: Snehal Patel Acquires 1,000 Shares of Greenwich LifeSciences Inc (GuruFocus.com)
Jul-26-23 01:12PM	Daily Vickers Top Buyers & Sellers for 07/26/2023 (Argus Research)
Jul-18-23 06:53AM	Daily Vickers Top Buyers & Sellers for 07/18/2023 (Argus Research)
May-10-23 06:32AM	Daily Vickers Top Insider Picks for 05/10/2023 (Argus Research)
May-09-23 06:40AM	Daily Vickers Top Insider Picks for 05/09/2023 (Argus Research)
May-08-23 06:41AM	Daily Vickers Top Insider Picks for 05/08/2023 (Argus Research)
May-05-23 06:58AM	Daily Vickers Top Insider Picks for 05/05/2023 (Argus Research)
May-04-23 06:29AM	Daily Vickers Top Insider Picks for 05/04/2023 (Argus Research)
May-03-23 06:46AM	Daily Vickers Top Insider Picks for 05/03/2023 (Argus Research) +5.02%
May-02-23 06:46AM	Daily Vickers Top Insider Picks for 05/02/2023 (Argus Research)
May-01-23 06:45AM	Daily Vickers Top Insider Picks for 05/01/2023 (Argus Research) +5.88%
Apr-28-23 07:04AM	Daily Vickers Top Insider Picks for 04/28/2023 (Argus Research)
Apr-27-23 06:47AM	Daily Vickers Top Insider Picks for 04/27/2023 (Argus Research)
Apr-26-23 06:26AM	Daily Vickers Top Insider Picks for 04/26/2023 (Argus Research)
Apr-20-23 07:03AM	Daily Vickers Top Insider Picks for 04/20/2023 (Argus Research)
Apr-19-23 06:53AM	Daily Vickers Top Insider Picks for 04/19/2023 (Argus Research)
Apr-17-23 06:54AM	Daily Vickers Top Insider Picks for 04/17/2023 (Argus Research)
Apr-14-23 06:37AM	Daily Vickers Top Insider Picks for 04/14/2023 (Argus Research)
Apr-13-23 06:52AM	Daily Vickers Top Insider Picks for 04/13/2023 (Argus Research)
Apr-12-23 07:07AM	Daily Vickers Top Insider Picks for 04/12/2023 (Argus Research) -5.41%
Apr-11-23 06:58AM	Daily Vickers Top Insider Picks for 04/11/2023 (Argus Research)
Apr-10-23 06:44AM	Daily Vickers Top Insider Picks for 04/10/2023 (Argus Research)
Apr-07-23 07:44AM	Daily Vickers Top Insider Picks for 04/07/2023 (Argus Research)
Apr-06-23 10:37AM	Insiders own 39% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) shares but retail investors control 42% of the company (Simply Wall St.)
07:20AM	Daily Vickers Top Insider Picks for 04/06/2023 (Argus Research)
Apr-05-23 06:11AM	Daily Vickers Top Insider Picks for 04/05/2023 (Argus Research)
Apr-04-23 07:08AM	Daily Vickers Top Insider Picks for 04/04/2023 (Argus Research)
Apr-03-23 06:48AM	Daily Vickers Top Insider Picks for 04/03/2023 (Argus Research)
Mar-31-23 06:36AM	Daily Vickers Top Insider Picks for 03/31/2023 (Argus Research)
Mar-30-23 06:36AM	Daily Vickers Top Insider Picks for 03/30/2023 (Argus Research)
Mar-29-23 06:32AM	Daily Vickers Top Insider Picks for 03/29/2023 (Argus Research) +8.37%
Mar-28-23 06:46AM	Daily Vickers Top Insider Picks for 03/28/2023 (Argus Research) -5.86%
Mar-24-23 06:42AM	Daily Vickers Top Insider Picks for 03/24/2023 (Argus Research)
Mar-23-23 07:01AM	Daily Vickers Top Insider Picks for 03/23/2023 (Argus Research)
Mar-21-23 06:23AM	Daily Vickers Top Insider Picks for 03/21/2023 (Argus Research) +9.36%
Mar-20-23 06:35AM	Daily Vickers Top Insider Picks for 03/20/2023 (Argus Research)
Mar-17-23 06:47AM	Daily Vickers Top Insider Picks for 03/17/2023 (Argus Research)
Mar-16-23 06:51AM	Daily Vickers Top Insider Picks for 03/16/2023 (Argus Research)
Mar-15-23 06:44AM	Daily Vickers Top Insider Picks for 03/15/2023 (Argus Research)
Mar-13-23 06:32AM	Daily Vickers Top Insider Picks for 03/13/2023 (Argus Research) +8.00%
Mar-10-23 07:04AM	Daily Vickers Top Insider Picks for 03/10/2023 (Argus Research) -6.05%
Mar-09-23 06:33AM	Daily Vickers Top Insider Picks for 03/09/2023 (Argus Research) -5.43%
Mar-08-23 06:30AM	Daily Vickers Top Insider Picks for 03/08/2023 (Argus Research)
Mar-07-23 06:34AM	Daily Vickers Top Insider Picks for 03/07/2023 (Argus Research) -5.65%
Mar-06-23 07:22AM	Daily Vickers Top Insider Picks for 03/06/2023 (Argus Research)
Mar-03-23 06:38AM	Daily Vickers Top Insider Picks for 03/03/2023 (Argus Research)
Mar-02-23 06:44AM	Daily Vickers Top Insider Picks for 03/02/2023 (Argus Research) -6.81%
Mar-01-23 06:01AM	Daily Vickers Top Insider Picks for 03/01/2023 (Argus Research)
Feb-28-23 06:43AM	Daily Vickers Top Insider Picks for 02/28/2023 (Argus Research)
Feb-27-23 06:50AM	Daily Vickers Top Insider Picks for 02/27/2023 (Argus Research)
Feb-24-23 07:17AM	Daily Vickers Top Insider Picks for 02/24/2023 (Argus Research) -7.28%
Feb-23-23 07:21AM	Daily Vickers Top Insider Picks for 02/23/2023 (Argus Research)
Feb-22-23 06:56AM	Daily Vickers Top Insider Picks for 02/22/2023 (Argus Research) +5.03%

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Patel Snehal	CEO and CFO	Jan 13 '26	Buy	29.83	1,800	53,694	5,604,102	Jan 15 06:05 AM
Patel Snehal	CEO and CFO	Jan 12 '26	Buy	27.54	2,900	79,866	5,602,302	Jan 14 06:05 AM
Patel Snehal	CEO and CFO	Dec 31 '25	Buy	21.36	4,300	91,848	5,599,402	Jan 05 06:06 AM
Patel Snehal	CEO and CFO	Dec 30 '25	Buy	21.73	2,900	63,017	5,595,102	Jan 02 06:05 AM
Patel Snehal	CEO and CFO	Dec 18 '25	Buy	12.62	4,100	51,742	5,592,202	Dec 19 06:05 AM
Patel Snehal	CEO and CFO	Nov 25 '25	Buy	8.37	4,600	38,502	5,588,102	Nov 28 06:05 AM
Patel Snehal	CEO and CFO	Nov 07 '25	Buy	8.43	10,600	89,358	5,583,502	Nov 12 06:05 AM
Patel Snehal	CEO and CFO	Oct 31 '25	Buy	9.26	2,300	21,298	5,572,902	Nov 04 06:16 AM
Patel Snehal	CEO and CFO	Apr 25 '25	Buy	9.88	3,600	35,568	5,570,602	Apr 29 06:14 AM
Patel Snehal	CEO and CFO	Apr 17 '25	Buy	8.98	5,400	48,492	5,567,002	Apr 22 06:05 AM
Patel Snehal	CEO and CFO	Apr 07 '25	Buy	9.10	3,600	32,760	5,561,602	Apr 08 06:05 AM
Patel Snehal	CEO and CFO	Apr 04 '25	Buy	8.73	5,500	48,015	5,558,002	Apr 07 07:50 AM

Open in Screener

GCTS

GCT Semiconductor Holding Inc

Feb 17 • 10:18AM ET

1.24

-0.02 -1.59 %

Technology • Semiconductors • USA • NYSE

GCTS GCT Semiconductor Holding Inc daily Stock Chart

Peers: QCOM AVGO SWKS NXPI MRVL ADI ON SLAB MCHP SYNA

| Held by: VTI VXF IWC

Index	-	P/E	-	EPS (ttm)	-0.76	Insider Own	28.76%	Shs Outstand	56.47M	Perf Week	-1.59%
Market Cap	70.81M	Forward P/E	-	EPS next Y	-0.55	Insider Trans	1.41%	Shs Float	40.68M	Perf Month	14.81%
Enterprise Value	127.61M	PEG	-	EPS next Q	-0.23	Inst Own	6.73%	Short Float	15.64%	Perf Quarter	-2.36%
Income	-39.33M	P/S	18.20	EPS this Y	-195.00%	Inst Trans	0.16%	Short Ratio	1.78	Perf Half Y	-1.59%
Sales	3.89M	P/B	-	EPS next Y	38.42%	ROA	-167.72%	Short Interest	6.36M	Perf YTD	3.33%
Book/sh	-1.42	P/C	8.49	EPS next 5Y	14.12%	ROE	-	52W High	2.47 -49.80%	Perf Year	-42.33%
Cash/sh	0.15	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	0.90 37.78%	Perf 3Y	-87.97%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-0.21%	Volatility	7.33% 12.18%	Perf 5Y	-
Dividend TTM	-	EV/Sales	32.80	EPS Y/Y TTM	-186.82%	Oper. Margin	-800.57%	ATR (14)	0.12	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.23	Sales Y/Y TTM	-46.98%	Profit Margin	-1010.20%	RSI (14)	54.66	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.25	EPS Q/Q	-60.06%	SMA20	7.01%	Beta	1.20	Target Price	3.50
Payout	-	Debt/Eq	-	Sales Q/Q	-83.52%	SMA50	1.15%	Rel Volume	0.83	Prev Close	1.26
Employees	121	LT Debt/Eq	-	Earnings	Nov 12 AMC	SMA200	-8.20%	Avg Volume	3.57M	Price	1.24
IPO	Dec 27, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	-31.58% -63.80%	Trades		Volume	494,999	Change	-1.59%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-11-25	Initiated	H.C. Wainwright	Buy	$3
Aug-28-24	Initiated	B. Riley Securities	Buy	$8

Feb-11-26 06:55AM	GCT Semiconductor Partners with Skylo to Accelerate Global Satellite Connectivity (Business Wire)
Jan-30-26 01:14AM	Why GCT Semiconductor Stock Popped - Then Dropped - After Its Satellite Deal (Benzinga) -7.94%
Jan-29-26 08:00AM	Telo Genomics Announces Appointment of John Price as Chief Financial Officer (TMX Newsfile) +27.13%
06:55AM	GCT Semiconductor Announces Licensing Agreement with Leading Satellite Communications Provider to Accelerate Global 5G Connectivity (Business Wire)
Jan-16-26 10:25AM	GCT Semiconductor (GCTS) Starts Commercial 5G Shipments, H.C. Wainwright Stays Bullish (Insider Monkey)
02:29PM	Loading…
Jan-07-26 02:29PM	The 3 Best Chip Stocks to Buy for 2026 Are Companies You Have Probably Never Heard Of (Barchart)
Jan-06-26 08:00AM	GCT Semiconductor Launches Commercial Shipments of 5G Chipset (Business Wire)
Nov-13-25 12:02AM	GCT Semiconductor Holding Inc (GCTS) Q3 2025 Earnings Call Highlights: Pioneering 5G Revenue ... (GuruFocus.com) -12.41%
Nov-12-25 04:05PM	GCT Semiconductor Holding, Inc. Provides Business Update and Reports Third Quarter 2025 Financial Results (Business Wire) +6.62%
Oct-29-25 08:00AM	GCT Semiconductor Holding, Inc. to Give Business Update and Announce Third Quarter 2025 Financial Results on November 12, 2025 (Business Wire)
Sep-11-25 08:00AM	GCT Semiconductor Announces $10.7M Debt Financing in Preparation of 5G Volume Shipments (Business Wire)
Aug-21-25 08:05AM	New Strong Sell Stocks for August 21st (Zacks)
Aug-20-25 08:00AM	GCT Semiconductor Successfully Completes Sampling of 5G Chipsets and Modules to Lead Customers (Business Wire)
Aug-15-25 06:34AM	New Strong Sell Stocks for August 15th (Zacks) -5.97%
Aug-13-25 03:12AM	GCT Semiconductor Holding Inc (GCTS) Q2 2025 Earnings Call Highlights: Navigating the 5G ... (GuruFocus.com) -8.27%
05:25PM	Loading…
Aug-12-25 05:25PM	GCT Semiconductor Holding, Inc. (GCTS) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:05PM	GCT Semiconductor Holding, Inc. Provides Business Update and Reports Second Quarter 2025 Financial Results (Business Wire)
Aug-07-25 08:20PM	Synaptics (SYNA) Beats Q4 Earnings and Revenue Estimates (Zacks) +5.93%
Aug-06-25 06:00PM	SkyWater Technology, Inc. (SKYT) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Jul-29-25 08:00AM	GCT Semiconductor Holding, Inc. to Give Business Update and Announce Second Quarter 2025 Financial Results on August 12, 2025 (Business Wire)
Jul-23-25 09:46AM	Airspan Completes Industry-First 5G Air-to-Ground Call (Business Wire)
Jul-21-25 12:21AM	GCT Semiconductor (GCTS) Delivers Latest 5G Chips for Testing (Insider Monkey)
Jun-30-25 11:56AM	QuickLogic (QUIK) Moves 5.9% Higher: Will This Strength Last? (Zacks)
Jun-27-25 03:10AM	Iridium Communications, GCT Semiconductor Partner to Accelerate 5G Satellite IoT Development (Insider Monkey)
Jun-18-25 07:00AM	Gogo successfully completes first 5G end-to-end call. (GlobeNewswire)
Jun-11-25 08:00AM	GCT Semiconductor Celebrates Major Milestone with Delivery of 5G Chipsets and Modules to Customers (Business Wire) +6.96%
Jun-04-25 08:00AM	GCT Semiconductor and Iridium Sign MOU to Collaborate on Integrating Iridium NTN Direct Service into GCT Chipset (Business Wire)
May-22-25 08:00AM	GCT Semiconductor and Giesecke+Devrient Partner to Launch Innovative eSIM Solution for IoT Devices (Business Wire)
May-15-25 12:56PM	GCT Semiconductor Announces $11 Million Registered Direct Offering (Business Wire) -40.45%
May-14-25 05:35PM	GCT Semiconductor Holding, Inc. (GCTS) Reports Q1 Loss, Misses Revenue Estimates (Zacks) +30.95%
04:05PM	Loading…
04:05PM	GCT Semiconductor Holding, Inc. Provides Business Update and Reports First Quarter 2025 Financial Results (Business Wire)
May-13-25 05:55PM	Pixelworks (PXLW) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-09-25 12:10PM	Wolfspeed Q3 Earnings Beat Estimates, Revenues Decline Y/Y (Zacks)
May-08-25 06:25PM	Synaptics (SYNA) Q3 Earnings and Revenues Surpass Estimates (Zacks)
11:06AM	Fortinet Q1 Earnings Surpass Expectations, Sales Increase Y/Y (Zacks)
Apr-30-25 08:00AM	GCT Semiconductor Holding, Inc. to Give Business Update and Announce First Quarter 2025 Financial Results on May 14, 2025 (Business Wire)
Apr-16-25 08:00AM	Orbic North America and GCT Semiconductor Sign LOI to Develop and Supply Orbic-Branded FWA Gateway and Mobile Hotspot with GCTs Verizon-Certified 5G Module (Business Wire)
Mar-28-25 12:00PM	GCT Semiconductor Holding, Inc. (GCTS) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Mar-25-25 07:45PM	GCT Semiconductor Holding, Inc. (GCTS) Q4 2024 Earnings Call Transcript (SeekingAlpha) -16.75%
04:05PM	GCT Semiconductor Holding, Inc. Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
Mar-11-25 08:00AM	GCT Semiconductor Holding, Inc. to Give Business Update and Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 (Business Wire)
Mar-04-25 08:00AM	GCT Semiconductor and Globalstar Partner to Develop IoT Modules for Two-Way Satellite, Cellular and Band 53 Connectivity (Business Wire)
Feb-11-25 08:00AM	GCT Semiconductor to Attend Oppenheimer's 10th Annual Emerging Growth Conference and ROTH's 37th Annual ROTH Conference (Business Wire)
Feb-04-25 08:36AM	GCT Semiconductor price target lowered to $5 from $8 at B. Riley (TipRanks)
Jan-17-25 07:00AM	GCT Semiconductor Participates in Exclusive Aramco Digital and 450 MHz Alliance Event on Innovations in Private Networks (Business Wire)
Dec-03-24 08:30AM	Sidoti Events, LLC's Virtual December Small-Cap Conference (ACCESS Newswire)
Nov-25-24 06:30AM	GCT Semiconductor Holding, Inc. Signs Strategic Definitive Agreement with European Tier One Telecommunications Supplier (Business Wire) -6.33%
Nov-14-24 04:05PM	GCT Semiconductor Holding, Inc. Reports Third Quarter 2024 Financial Results (Business Wire) -12.83%
Nov-12-24 08:00AM	GCT Semiconductor Holding, Inc. to Attend the 13th Annual ROTH Technology Conference on November 20 (Business Wire)
Oct-31-24 08:00AM	GCT Semiconductor Holding, Inc. to Announce Third Quarter Financial Results and Hold Conference Call on November 14, 2024 (Business Wire) -6.48%
Sep-03-24 03:01AM	Strategic Partnership of Five Tech Leaders for End-to-End Solutions Within 450MHz Ecosystems (Business Wire) -5.71%
Aug-29-24 07:00AM	GCT Semiconductor Holding, Inc. to Present at the 2024 Gateway Conference on September 4th (GlobeNewswire) -5.05%
Aug-20-24 08:00AM	GCT Semiconductor Holding, Inc. Signs MOU with Global Tier One Telecommunications Supplier (Business Wire)
Aug-14-24 04:05PM	GCT Semiconductor Holding, Inc. Reports Second Quarter 2024 Financial Results (Business Wire) +5.28%
Aug-13-24 06:45AM	GCT Semiconductor Signs MOU with Samsung to Accelerate the Development of 4G/5G Chipsets and Modules (Business Wire) +10.59%
Jul-31-24 08:00AM	GCT Semiconductor Holding, Inc. to Announce Second Quarter Financial Results and Hold Conference Call on August 14, 2024 (Business Wire)
Jul-23-24 08:00AM	GCT Semiconductor and Ligado Networks Announce Commercial Availability of Band 54 Modules (Business Wire)
Jul-16-24 10:00AM	Gateway Group Announces Preliminary Sponsors and Additional Presenting Companies for September Gateway Conference (GlobeNewswire)
Jul-10-24 08:00AM	GCT Semiconductor and Kyocera Sign Development and Partnership Agreement for Collaboration on a 5G Reference Platform for CPE Devices (Business Wire)
Jul-01-24 08:00AM	GCT Semiconductor Holding Announces Inclusion in Russell 3000 Index (Business Wire)
Jun-10-24 07:32AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) +16.12%
May-28-24 08:05AM	GCT Semiconductor Announces the Worlds First Highly Integrated Multi-Mode LTE Chipset Supporting the 450 MHz Spectrum (Business Wire) -8.62%
May-14-24 10:56PM	GCTS Stock Earnings: GCT Semiconductor Hldgs Reported Results for Q1 2024 (InvestorPlace) -6.12%
04:05PM	GCT Semiconductor Holding, Inc. Reports First Quarter 2024 Financial Results (Business Wire)
May-07-24 10:00AM	Gateway Group Announces Preliminary Presenting Companies for Gateway Conference in San Francisco on September 4-5, 2024 (GlobeNewswire)
Apr-05-24 08:00AM	Aramco and GCT Semiconductor Holding, Inc. Sign MOU to Accelerate the Development of the 4G and 5G Ecosystem in Saudi Arabia (Business Wire) +42.41%
Apr-01-24 08:00AM	GCT Semiconductor Appoints Nelson C. Chan to Board of Directors (Business Wire) -45.28%
Mar-26-24 06:30PM	GCT Semiconductor Becomes a Publicly Traded Company After Completing Business Combination with Concord Acquisition Corp III, Will Commence Trading on NYSE Under Ticker Symbol "GCTS" (Business Wire) -34.46% +568.69%
Mar-22-24 04:00PM	GCT Semiconductor Announces Appointment of Edmond Cheng as Chief Financial Officer (Business Wire) -10.72%
Feb-15-24 04:00PM	GCT Semiconductor and Concord Acquisition Corp III Announce Effectiveness of Registration Statement on Form S-4 (Business Wire)
Jan-25-24 08:00AM	Concord Acquisition Corp III Receives Noncompliance Notification from the New York Stock Exchange Regarding Minimum Public Stockholders (PR Newswire)
Nov-03-23 08:00AM	GCT Semiconductor to Become Publicly Listed via Merger with Concord Acquisition Corp III, Enhancing the 5G Silicon Ecosystem (Business Wire)

GCT Semiconductor Holding, Inc. engages in the design, manufacture, and sale of semiconductor products. It offers baseband modem, wireless broadband, and chip radio frequency transceivers. The company was founded by Kyeong-Ho Lee on June 15, 1998 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Shin Hyunsoo	Class II Director	Nov 25 '25	Buy	1.28	16,725	21,408	757,771	Nov 28 08:46 AM
Shin Hyunsoo	Class II Director	Nov 20 '25	Buy	1.28	25,453	32,580	737,866	Nov 24 04:31 PM
Shin Hyunsoo	Class II Director	Nov 21 '25	Buy	1.28	3,180	4,070	741,046	Nov 24 04:31 PM
Shin Hyunsoo	Class II Director	Sep 12 '25	Buy	1.51	44,067	66,541	694,321	Sep 16 04:16 PM
Shin Hyunsoo	Class II Director	Sep 05 '25	Buy	1.30	10,300	13,390	650,254	Sep 08 04:04 PM
Shin Hyunsoo	Class II Director	Sep 04 '25	Buy	1.26	8,250	10,395	639,954	Sep 08 04:04 PM
Shin Hyunsoo	Class II Director	Aug 15 '25	Buy	1.26	121,000	152,460	631,704	Aug 19 04:00 PM
Shin Hyunsoo	Class II Director	Jun 10 '25	Buy	1.18	85,000	100,200	492,248	Jun 12 09:11 AM
Shin Hyunsoo	Class II Director	Jun 05 '25	Buy	1.03	80,000	82,187	407,248	Jun 06 04:03 PM
Shin Hyunsoo	Class II Director	Jun 04 '25	Buy	1.02	80,000	81,600	327,248	Jun 06 04:03 PM
Shin Hyunsoo	Class II Director	May 23 '25	Buy	1.04	77,000	80,080	247,248	May 27 04:05 PM
Shin Hyunsoo	Class II Director	May 20 '25	Buy	1.18	86,000	101,480	170,248	May 21 04:39 PM
Sum Alex	Sr. VP of Sales and Marketing	Feb 19 '25	Option Exercise	0.11	13,259	1,458	108,743	Feb 21 06:02 PM

Open in Screener

ICCC

Immucell Corp

Feb 17 • 10:18AM ET

6.45

-0.15 -2.27 %

Healthcare • Biotechnology • USA • NASD

Peers: ZTS IDXX ELAN BIO PAHC ONC QGEN OPK CTLT PGEN

| Held by: VTI VXF IWC DFAT DCOR DFSU DFAC DXUV

Index	-	P/E	24.91	EPS (ttm)	0.26	Insider Own	37.67%	Shs Outstand	9.05M	Perf Week	-2.86%
Market Cap	58.34M	Forward P/E	-	EPS next Y	-	Insider Trans	0.38%	Shs Float	5.64M	Perf Month	-2.86%
Enterprise Value	68.06M	PEG	-	EPS next Q	-	Inst Own	14.44%	Short Float	0.22%	Perf Quarter	6.61%
Income	2.32M	P/S	2.10	EPS this Y	-	Inst Trans	10.16%	Short Ratio	0.47	Perf Half Y	5.69%
Sales	27.77M	P/B	1.96	EPS next Y	-	ROA	5.15%	Short Interest	0.01M	Perf YTD	4.88%
Book/sh	3.29	P/C	15.00	EPS next 5Y	-	ROE	8.27%	52W High	7.60 -15.13%	Perf Year	27.72%
Cash/sh	0.43	P/FCF	81.03	EPS past 3/5Y	-194.88% -6.81%	ROIC	5.57%	52W Low	4.28 50.70%	Perf 3Y	-11.64%
Dividend Est.	-	EV/EBITDA	13.50	Sales past 3/5Y	11.25% 14.06%	Gross Margin	40.93%	Volatility	4.46% 4.83%	Perf 5Y	-41.52%
Dividend TTM	-	EV/Sales	2.45	EPS Y/Y TTM	153.32%	Oper. Margin	8.39%	ATR (14)	0.29	Perf 10Y	4.20%
Dividend Ex-Date	-	Quick Ratio	1.76	Sales Y/Y TTM	16.49%	Profit Margin	8.37%	RSI (14)	53.30	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	4.21	EPS Q/Q	82.07%	SMA20	1.62%	Beta	0.27	Target Price	-
Payout	-	Debt/Eq	0.46	Sales Q/Q	-8.41%	SMA50	4.04%	Rel Volume	0.23	Prev Close	6.60
Employees	75	LT Debt/Eq	0.40	Earnings	Jan 08 AMC	SMA200	5.05%	Avg Volume	26.49K	Price	6.45
IPO	May 05, 1987	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	1,037	Change	-2.27%

Jan-15-26 11:24AM	Niche Focus & Regulation Shape the Future of Healthcare Firms (Zacks)
Jan-09-26 11:02AM	ImmuCell Q4 Earnings Call Highlights (MarketBeat)
Jan-08-26 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025 (GlobeNewswire) +5.29%
Jan-07-26 08:10AM	ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus (GlobeNewswire)
Dec-26-25 01:53AM	The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio (Zacks) +5.52%
01:10PM	Loading…
Dec-24-25 01:10PM	Top Stock Reports for AbbVie, Coca-Cola & Chevron (Zacks)
01:05PM	ImmuCell Announces Strategic Focus on First Defense After Receiving an FDA Incomplete Letter for Re-Tain (GlobeNewswire)
Dec-04-25 11:14AM	ImmuCell's Two-Product Edge in Cattle Health Fuels Growth (Zacks)
Nov-24-25 08:02PM	ImmuCell Corp (ICCC) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Nov-20-25 07:42AM	ICCC Stock Down Despite Y/Y Q3 Earnings Improvement & Margin Strength (Zacks)
Nov-13-25 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025 (GlobeNewswire) -10.74%
Nov-06-25 04:05PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025 (GlobeNewswire)
Nov-04-25 04:05PM	ImmuCell Announces Onboarding of New CEO and Related Management Changes (GlobeNewswire) +5.00%
Oct-09-25 09:37AM	The Zacks Analyst Blog Highlights SAP, Novartis, Philip Morris International, ImmuCell and ClearOne (Zacks)
Oct-08-25 05:07PM	Top Stock Reports for SAP, Novartis & Philip Morris (Zacks)
04:05PM	Loading…
Oct-07-25 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025 (GlobeNewswire)
Sep-29-25 04:05PM	ImmuCell Announces Selection of its Next President and CEO (GlobeNewswire)
Sep-09-25 12:57PM	FONAR's Stock Advances 5% in Three Months: Key Trends Ahead (Zacks) -6.03%
Aug-21-25 10:47AM	ImmuCell Swings to Q2 Profit on Strong Sales, Shares Still Slide (Zacks)
Aug-18-25 09:00AM	ImmuCell Corp (ICCC) Q2 2025 Earnings Call Highlights: Strong Sales Growth and Margin Expansion ... (GuruFocus.com)
Aug-14-25 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025 (GlobeNewswire) -9.18%
Aug-12-25 04:05PM	ImmuCell Announces Bank Debt Refinancing (GlobeNewswire)
Aug-07-25 08:00AM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2025 (GlobeNewswire)
Jul-22-25 11:55AM	ImmuCell Upgraded to Outperform on Sales Surge & FDA Upside (Zacks)
Jul-18-25 09:43AM	The Zacks Analyst Blog Highlights Alphabet, Oracle, Shell, Fossil and ImmuCell (Zacks)
Jul-17-25 11:46PM	Top Research Reports for Alphabet, Oracle & Shell (Zacks)
Jul-09-25 08:00AM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 of 2025 (GlobeNewswire)
Jun-25-25 08:00AM	ImmuCell Embarks on CEO Succession Planning Process (GlobeNewswire) -10.78%
Jun-05-25 06:30AM	ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders (GlobeNewswire)
May-19-25 11:36AM	ImmuCell Reports Y/Y Q1 Earnings Growth on Record Sales & Margin Gains (Zacks)
05:00PM	Loading…
May-16-25 05:00PM	ImmuCell Corp (ICCC) Q1 2025 Earnings Call Highlights: Record Sales and Strategic Growth Amid ... (GuruFocus.com)
May-14-25 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2025 (GlobeNewswire) +7.94%
May-12-25 08:42AM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025 (GlobeNewswire)
Apr-17-25 04:23AM	The Zacks Analyst Blog Netflix, SAP SE, Shell, Preformed Line Products and ImmuCell (Zacks)
Apr-16-25 05:02PM	Top Stock Reports for Netflix, SAP & Shell (Zacks)
Apr-08-25 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025 (GlobeNewswire) -10.59%
Apr-07-25 09:00AM	ImmuCell Hires Chief Financial Officer (GlobeNewswire)
Apr-02-25 04:05PM	ImmuCell Announces Initiation of Investigational Product Use of Re-Tain® (GlobeNewswire) +8.40%
Feb-27-25 04:00PM	ImmuCell Corp (ICCC) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Operational ... (GuruFocus.com)
Feb-25-25 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024 (GlobeNewswire) +7.45%
Feb-20-25 08:19AM	ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2024 (GlobeNewswire)
Jan-16-25 04:05PM	ImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses (GlobeNewswire) +5.16%
Jan-09-25 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024 (GlobeNewswire)
Nov-13-24 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024 (GlobeNewswire)
Nov-07-24 08:30AM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024 (GlobeNewswire)
Oct-08-24 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024 (GlobeNewswire)
Aug-13-24 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024 (GlobeNewswire)
Aug-07-24 04:05PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024 (GlobeNewswire)
Jul-09-24 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024 (GlobeNewswire)
Jun-05-24 04:05PM	ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain (GlobeNewswire)
Jun-04-24 04:05PM	ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders (GlobeNewswire)
May-14-24 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024 (GlobeNewswire) -10.89%
May-08-24 01:00PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024 (GlobeNewswire)
Apr-09-24 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024 (GlobeNewswire)
Feb-29-24 08:25AM	ImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 (GlobeNewswire)
Feb-16-24 09:30AM	ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 (GlobeNewswire)
Jan-08-24 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023 (GlobeNewswire) +5.01%
Nov-15-23 02:04PM	ImmuCell Corporation (NASDAQ:ICCC) Q3 2023 Earnings Call Transcript (Insider Monkey) -5.28%
Nov-13-23 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023 (GlobeNewswire)
Nov-07-23 12:15PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023 (GlobeNewswire)
Oct-05-23 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023 (GlobeNewswire)
Aug-29-23 08:00AM	ImmuCell Announces Submission of CMC Technical Section to the FDA (GlobeNewswire)
Aug-11-23 10:16PM	Q2 2023 ImmuCell Corp Earnings Call (Thomson Reuters StreetEvents)
Aug-10-23 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023 (GlobeNewswire)
Aug-07-23 12:00PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023 (GlobeNewswire)
Jul-11-23 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023 (GlobeNewswire)
Jun-28-23 04:05PM	ImmuCell Announces Change in Timing of Anticipated FDA Submission (GlobeNewswire) -10.35%
Jun-21-23 04:05PM	ImmuCell Appoints Bryan K. Gathagan to Board of Directors (GlobeNewswire)
Jun-15-23 04:05PM	ImmuCell Announces Approval of Principal Terms of a $3 Million Debt Facility (GlobeNewswire) +8.53%
May-16-23 09:00AM	ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders (GlobeNewswire)
May-15-23 07:36AM	There's No Escaping ImmuCell Corporation's (NASDAQ:ICCC) Muted Revenues (Simply Wall St.) +7.11%
May-12-23 09:46PM	Q1 2023 ImmuCell Corp Earnings Call (Thomson Reuters StreetEvents) -6.46%
May-11-23 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023 (GlobeNewswire)
May-04-23 06:30AM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023 (GlobeNewswire)
Apr-05-23 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2023 (GlobeNewswire)
Feb-23-23 05:26AM	ImmuCell Full Year 2022 Earnings: US$0.32 loss per share (vs US$0.01 loss in FY 2021) (Simply Wall St.)
Feb-21-23 04:05PM	ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2022 (GlobeNewswire) -6.84%
Feb-15-23 11:55AM	ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2022 (GlobeNewswire)
Jan-09-23 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2022 (GlobeNewswire) +8.55%
Dec-23-22 10:24PM	ImmuCell Corporation (NASDAQ:ICCC) Q3 2022 Earnings Call Transcript (Insider Monkey)
Nov-21-22 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2022 (GlobeNewswire) -11.27%
Nov-10-22 04:05PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2022 (GlobeNewswire)
Oct-24-22 06:20AM	Investors in ImmuCell (NASDAQ:ICCC) have made a decent return of 48% over the past three years (Simply Wall St.)
Oct-05-22 06:30AM	ImmuCell Announces Preliminary, Unaudited Sales Results for Third Quarter of 2022 (GlobeNewswire)
Sep-14-22 05:00PM	ImmuCell to Participate in the Lytham Partners Fall 2022 Investor Conference (GlobeNewswire)
Aug-12-22 09:00AM	Edited Transcript of ICCC.OQ earnings conference call or presentation 12-Aug-22 1:00pm GMT (Thomson Reuters StreetEvents) -6.86%
Aug-11-22 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2022 (GlobeNewswire)
Aug-05-22 09:24AM	Does ImmuCell (NASDAQ:ICCC) Have A Healthy Balance Sheet? (Simply Wall St.)
Aug-04-22 06:30AM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2022 (GlobeNewswire)
Jul-27-22 08:05PM	ImmuCell Receives Technical Section Incomplete Letter from FDA Pertaining to Re-Tain® (GlobeNewswire)
Jul-07-22 06:30AM	ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022 (GlobeNewswire)
Jun-15-22 03:10PM	Is ImmuCell Corporation's (NASDAQ:ICCC) Stock Price Struggling As A Result Of Its Mixed Financials? (Simply Wall St.)
May-19-22 08:00AM	ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders (GlobeNewswire)
May-16-22 02:12PM	ImmuCell's (NASDAQ:ICCC) investors will be pleased with their respectable 35% return over the last five years (Simply Wall St.)
May-12-22 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2022 (GlobeNewswire)
May-10-22 10:00AM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2022 (GlobeNewswire) -8.08%
May-05-22 01:18PM	UPDATE -- Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement (GlobeNewswire)
11:17AM	Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement (GlobeNewswire)
Apr-11-22 04:05PM	ImmuCell Announces Record Preliminary, Unaudited Sales Results for First Quarter of 2022 (GlobeNewswire)

ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kits, and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
te Boekhorst Paul Francis Oliv	President and CEO	Dec 03 '25	Buy	5.02	6,077	30,536	9,785	Dec 03 04:14 PM
te Boekhorst Paul Francis Oliv	President and CEO	Dec 02 '25	Buy	4.87	3,708	18,053	3,708	Dec 03 04:14 PM
Tomsche David Scott	Director	Nov 25 '25	Buy	4.76	1,633	7,781	4,740	Nov 28 08:12 AM
Tomsche David Scott	Director	Nov 25 '25	Buy	4.76	1,633	7,773	52,720	Nov 28 08:12 AM
Basse Gloria F	Director	Jun 11 '25	Option Exercise	4.81	3,530	16,979	3,530	Jun 13 01:05 PM

Open in Screener

MAIA

MAIA Biotechnology Inc

Feb 17 • 10:18AM ET

1.87

-0.05 -2.86 %

Healthcare • Biotechnology • USA • AMEX

MAIA MAIA Biotechnology Inc daily Stock Chart

Peers: PDSB FATE AVXL IONS AFMD PTGX ONCT BCLI ADMA VSTM

Index	-	P/E	-	EPS (ttm)	-0.74	Insider Own	23.64%	Shs Outstand	34.45M	Perf Week	-5.81%
Market Cap	69.06M	Forward P/E	-	EPS next Y	-0.69	Insider Trans	4.76%	Shs Float	28.28M	Perf Month	17.30%
Enterprise Value	58.17M	PEG	-	EPS next Q	-0.13	Inst Own	6.72%	Short Float	7.01%	Perf Quarter	84.65%
Income	-22.34M	P/S	-	EPS this Y	50.17%	Inst Trans	2.06%	Short Ratio	2.19	Perf Half Y	18.04%
Sales	0.00M	P/B	1541.32	EPS next Y	6.76%	ROA	-212.50%	Short Interest	1.98M	Perf YTD	21.90%
Book/sh	0.00	P/C	6.34	EPS next 5Y	-	ROE	-2691.06%	52W High	3.19 -41.54%	Perf Year	-0.27%
Cash/sh	0.29	P/FCF	-	EPS past 3/5Y	3.77% -11.40%	ROIC	-53610.15%	52W Low	0.87 114.37%	Perf 3Y	-58.83%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	11.22% 13.83%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	44.50%	Oper. Margin	-	ATR (14)	0.23	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.18	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	47.23	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.18	EPS Q/Q	-134.24%	SMA20	-15.20%	Beta	0.04	Target Price	14.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	6.93%	Rel Volume	0.45	Prev Close	1.92
Employees	13	LT Debt/Eq	0.00	Earnings	Nov 04	SMA200	14.90%	Avg Volume	904.83K	Price	1.87
IPO	Jul 28, 2022	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	67,850	Change	-2.86%

Feb-05-26 09:35AM	$207B Market Shift: The Race for Fast Track Approval in Oncology (PR Newswire) -10.75%
Jan-28-26 09:15AM	Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment (PR Newswire) -5.76%
Jan-20-26 10:15AM	MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum (GlobeNewswire) +26.44%
Dec-24-25 08:01AM	MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings (GlobeNewswire) +8.82%
Dec-16-25 04:15PM	MAIA Biotechnology Announces $1.51 Million Private Placement (GlobeNewswire) -8.89% -6.50%
01:00PM	Loading…
Dec-11-25 01:00PM	MAIA's Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates (GlobeNewswire) +18.84%
09:00AM	MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer (GlobeNewswire)
08:00AM	MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential (GlobeNewswire)
Dec-10-25 02:00PM	MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach (GlobeNewswire)
Dec-01-25 09:17AM	MAIA Biotechnology Announces Open Market Purchases by CEO and Directors (GlobeNewswire)
Nov-21-25 09:01AM	MAIA Biotechnology Highlights Ongoing Momentum of Ateganosine Clinical Program at SITC 2025 (GlobeNewswire)
Nov-20-25 08:47AM	MAIA Biotechnology CEO Presents Telomere Targeting Efficacy at Romania's 2025 Smart Diaspora Conference on Oncology Research and Innovation (GlobeNewswire) -5.33%
Oct-27-25 10:45AM	MAIA Biotechnology Presents Trial in Progress Poster at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (GlobeNewswire)
Oct-23-25 08:36AM	MAIA Biotechnology Details 30-Month Patient Survival in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer (GlobeNewswire) +7.35%
Oct-13-25 04:20PM	MAIA Biotechnology Announces $736,600 Private Placement (GlobeNewswire) -6.37%
03:13PM	Loading…
Oct-07-25 03:13PM	Cancer drug maker takes sudden pivot into crypto (TheStreet)
08:47AM	MAIA Biotechnology to Initiate Digital Asset Treasury Strategy Focused on Top-Tier Crypto Assets (GlobeNewswire)
Sep-29-25 04:30PM	MAIA Biotechnology Announces $2.25 Million Private Placement (GlobeNewswire)
Sep-24-25 08:01AM	MAIA Biotechnology Awarded $2.3 Million Grant by National Institutes of Health for THIO-101 Phase 2 Trial of Cancer-Fighting Agent (GlobeNewswire)
Sep-12-25 08:33AM	Maias NSCLC immunotherapy secures Phase II efficacy win (Clinical Trials Arena)
Sep-11-25 09:27AM	MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung Cancer (GlobeNewswire) +8.97%
Sep-05-25 09:03AM	MAIA Biotechnology Abstract Selected for Poster Presentation at 2025 IASLC World Conference on Lung Cancer (GlobeNewswire)
Aug-27-25 09:01AM	MAIA Biotechnology Announces Publication of Interim Clinical Data on Telomere Targeting Anticancer Agent in Peer-Reviewed Journal Cells (GlobeNewswire) +7.14%
Aug-18-25 08:00AM	Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) (GlobeNewswire)
Aug-13-25 09:01AM	MAIA Biotechnology Granted European Patent for Next Generation Telomere-Targeting Agents for Cancer Therapy (GlobeNewswire)
Jul-28-25 08:01AM	MAIA Biotechnology Receives FDAs Fast Track Designation for Ateganosine as a Treatment for Non-Small Cell Lung Cancer (Business Wire)
Jul-17-25 09:17AM	MAIA Biotechnology Announces Peer-Reviewed Journal Publication of Data Validating Second Generation Ateganosine Prodrugs for Anticancer Therapy (Business Wire)
Jul-10-25 10:40AM	MAIA Biotechnology doses first patient in expansion of Phase II lung cancer trial (Clinical Trials Arena)
Jul-09-25 09:15AM	MAIA Biotechnology Announces First Patient Dosed in Expansion of Phase 2 Trial for Ateganosine in Advanced Non-Small Cell Lung Cancer (Business Wire) +9.24%
Jul-01-25 09:00AM	MAIA Biotechnology to Present Two Posters Featuring Cancer Telomere-Targeting Agents at FEBS 2025 Congress (Business Wire) +6.67%
08:15AM	Loading…
Jun-24-25 08:15AM	MAIA Biotechnology Welcomes Leading Hepatocellular Carcinoma Clinician-Scientists to Scientific Advisory Board (Business Wire)
Jun-19-25 09:25AM	MAIA Biotechnology, Roche sign supply agreement for cancer therapies (TipRanks)
Jun-18-25 09:15AM	MAIA Biotechnology Announces Master Clinical Supply Agreement with Roche for Hard-to-Treat Cancer Therapies (Business Wire) +8.43%
Jun-10-25 08:46AM	MAIA Biotechnology to Present at BIO International Convention 2025 (Business Wire)
Jun-05-25 02:28PM	MAIA Biotechnology's Experimental Cancer Drug Shows Tripled Survival Vs. Standard Chemotherapy In Pretreated Lung Cancer Patients (Benzinga) +10.80%
11:10AM	MAIA Biotechnology Announces New Responder in Non-Small Cell Lung Cancer Phase 2 Clinical Trial (Business Wire)
08:04AM	MAIA Biotechnology Announces Positive Efficacy Update for Phase 2 THIO-101 Clinical Trial in Non-Small Cell Lung Cancer (Business Wire)
May-27-25 08:29PM	MAIA Biotechnology, Inc. (MAIA) Raises $695K in Private Placement to Advance Cancer Trial (Insider Monkey)
05:35PM	CORRECTING and REPLACING MAIA Biotechnology Announces Private Placement of Approximately $695,000 (Business Wire)
May-15-25 11:05AM	MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting (Business Wire)
May-14-25 10:15AM	MAIA Biotechnology Announces Director Participation in Recent Private Placement (Business Wire)
May-06-25 10:00AM	Best Momentum Stocks to Buy for May 6th (Zacks) +7.85%
07:41AM	New Strong Buy Stocks for May 6th (Zacks)
May-05-25 11:45PM	CORRECTION: MAIA Biotechnology Announces $1.08 Million Private Placement (Business Wire) -6.83%
04:05PM	MAIA Biotechnology Announces $1.08 Million Private Placement (Business Wire)
Apr-01-25 08:30AM	MAIA Biotechnology CEO Details Anticipated Clinical Milestones for Novel Cancer Immunotherapy in 2025 Letter to Shareholders (Business Wire)
Mar-28-25 10:39AM	Is MAIA Biotechnology, Inc. (MAIA)he Cheapest Stock Insiders Are Buying In March? (Insider Monkey)
Mar-27-25 12:00PM	MAIA Biotechnology, Inc. (MAIA) Upgraded to Buy: Here's What You Should Know (Zacks)
Mar-25-25 08:46AM	MAIA Biotechnology Announces Poster Presentation at ESMO's European Lung Cancer Congress 2025 (Business Wire) -5.99%
Mar-20-25 09:20AM	MAIA Biotechnology Announces Publication of Peer-Reviewed Study Featuring Potency and Potential of Novel THIO Prodrug (Business Wire)
Mar-19-25 11:00AM	MAIA Biotechnology Receives USAN Council Approval for "Ateganosine" as Nonproprietary Name for Anticancer Agent THIO (Business Wire)
Feb-27-25 08:51AM	MAIA Biotechnology to Initiate Phase 3 Pivotal Trial of THIO Sequenced with Checkpoint Inhibitor Compared with Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer Patients (Business Wire) +7.07%
Feb-26-25 08:47AM	MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung Cancer (Business Wire) +5.75%
Feb-24-25 04:30PM	MAIA Biotechnology Announces Non-Brokered Private Placement of Approximately $1.43 Million (Business Wire)
Feb-18-25 03:44PM	MAIA Biotechnology Announces Private Placement of $2,715,000 (Business Wire)
Feb-04-25 08:51AM	MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer (Business Wire) +5.82%
Jan-10-25 09:45AM	MAIA Biotechnology to Present at Biotech Showcase 2025 (Business Wire)
Jan-07-25 09:12AM	MAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer Indications (Business Wire) +15.53%
Dec-19-24 08:47AM	MAIA Biotechnology Announces Director Participation in Recent Private Placement Closings (Business Wire) +5.15%
Dec-16-24 08:37AM	MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas (Business Wire) +10.00%
Dec-09-24 06:00PM	MAIA Biotechnology Announces Private Placement of Approximately $950,000 (Business Wire)
Dec-03-24 08:17AM	MAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung Cancer (Business Wire)
Nov-07-24 08:47AM	MAIA Biotechnology Announces Participation by Director Stan Smith, Ph.D. in Recent Private Placement (Business Wire)
Nov-05-24 09:45AM	MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting (Business Wire) +6.25%
Oct-28-24 07:00PM	MAIA Biotechnology Announces $2.44 Million Private Placement (Business Wire) +8.37%
Oct-15-24 08:15AM	MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics (Business Wire)
Sep-10-24 06:00AM	MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer (Business Wire) -5.75%
Sep-04-24 08:30AM	MAIA Biotechnology to Present New Phase 2 Clinical Trial Data at the H.C. Wainwright 26th Annual Global Investment Conference (Business Wire) +15.75%
Jul-23-24 04:11AM	MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent (Business Wire)
Jun-07-24 12:31PM	MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDAs Approval of a Telomerase Inhibitor Agent Therapy (Business Wire) +16.27%
Jun-06-24 10:07AM	MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent (Business Wire)
Jun-04-24 08:41AM	MAIA Biotechnology Reveals New Clinical Data Showing THIOs Strong Efficacy in Non-Small Cell Lung Cancer (Business Wire) -26.27%
May-17-24 08:37AM	MAIA Biotechnology to Present at the BIO International Convention 2024 (Business Wire) +6.09%
May-16-24 08:37AM	MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting (Business Wire) +8.71%
Apr-30-24 08:08AM	MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement (Business Wire) -8.72%
Apr-29-24 08:08AM	MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement (Business Wire) +9.18%
Apr-23-24 08:51AM	MAIA Biotechnology Announces $1.00 Million Private Placement (Business Wire) +8.85%
Apr-05-24 08:01AM	MAIA Biotechnology to Present at Two Investor Conferences in April 2024 (Business Wire) +6.82%
Mar-28-24 03:00PM	MAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrero (Business Wire) -11.29%
Mar-26-24 03:00PM	MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement (Business Wire)
08:01AM	MAIA Biotechnology Announces $1.33 Million Private Placement (Business Wire)
Mar-22-24 03:00PM	MAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private Placement (Business Wire) +8.76%
Mar-21-24 03:00PM	MAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory Board (Business Wire) +17.58%
Mar-16-24 01:49AM	Director Ngar Louie Acquires 170,940 Shares of MAIA Biotechnology Inc (MAIA) (GuruFocus.com)
Mar-07-24 09:45AM	MAIA Biotechnology to Participate in the 36th Annual ROTH Conference (Business Wire)
Mar-06-24 11:04AM	MAIA Biotechnology and Nationwide Childrens Hospital Announce Presentation of THIOs Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual Meeting (Business Wire)
08:48AM	MAIA Biotechnology Announces Strong Efficacy of THIO as Third-Line Treatment for Non-Small Cell Lung Cancer Patients (Business Wire)
Mar-05-24 08:45AM	MAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to Shareholders (Business Wire)
Feb-27-24 10:30AM	MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor (GlobeNewswire)
Feb-22-24 10:30AM	MAIA Biotechnology Completes Enrollment in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer (GlobeNewswire)
Feb-07-24 08:01AM	MAIA Biotechnology Announces Publication in Nature Communications on Positive Effects of THIO for Potential Treatment of Small Cell Lung Cancer (Business Wire)
Jan-24-24 07:15AM	MAIA Biotechnology Announces Publication of International PCT Patent Application Covering Anticancer Telomere-Targeting Compounds (Business Wire)
Jan-17-24 09:00AM	MAIA Biotechnology Provides Positive Phase 2 Clinical Updates for Lead Anticancer Agent and Outlines Targeted Milestones for 2024 (Business Wire) +20.33%
Jan-05-24 08:00AM	MAIA Biotechnology to Present at Biotech Showcase 2024 on January 9, 2024 (Business Wire) +26.89%
Dec-19-23 07:00AM	MAIA Biotechnology Announces Dose Selection in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer (Business Wire)
Dec-01-23 09:55AM	Bears are Losing Control Over MAIA Biotechnology, Inc. (MAIA), Here's Why It's a 'Buy' Now (Zacks)
Nov-17-23 03:52PM	MAIA Biotechnology Announces Closing of $4 Million Registered Direct Offering (Business Wire) -13.57%
09:00AM	MAIA Biotechnology (NYSE: MAIA) Has Received FDA Orphan Drug Designation For THIO As A Treatment For Most Aggressive Brain Cancer (ACCESSWIRE)
Nov-15-23 09:35AM	MAIA Biotechnology Announces $4 Million Registered Direct Offering (Business Wire) -24.73%
Nov-10-23 07:01AM	FDA Grants Orphan Drug Designation to MAIA Biotechnology for THIO as a Treatment for Glioblastoma (Business Wire)

MAIA Biotechnology, Inc. is a clinical stage biotechnology company that is engaged in the discovery, development and commercialization of therapies targeting cancer. Its product, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded on August 3, 2018 and is headquartered in Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Smith Stan	Director	Dec 22 '25	Buy	1.22	57,189	69,999	1,421,478	Dec 23 08:18 AM
CHAOUKI STEVEN M	Director	Dec 22 '25	Buy	1.22	40,849	49,999	151,873	Dec 23 08:16 AM
Louie Ngar Yee	Director	Dec 22 '25	Buy	1.22	81,699	100,000	1,248,888	Dec 23 08:14 AM
Smith Stan	Director	Dec 05 '25	Buy	1.20	13,740	16,441	4,580	Dec 09 04:51 PM
Vitoc Vlad	Chief Executive Officer	Nov 28 '25	Buy	1.14	50,000	56,830	881,421	Dec 01 06:20 AM
Vitoc Vlad	Chief Executive Officer	Nov 26 '25	Buy	1.05	22,000	23,019	853,421	Dec 01 06:20 AM
Luput Cristian	Director	Nov 26 '25	Buy	1.08	20,000	21,616	419,483	Dec 01 06:18 AM
Luput Cristian	Director	Nov 28 '25	Buy	1.11	18,145	20,230	437,628	Dec 01 06:18 AM
Smith Stan	Director	Nov 26 '25	Buy	1.04	15,000	15,582	1,364,289	Dec 01 06:14 AM
Luput Cristian	Director	Nov 25 '25	Buy	0.98	10,000	9,785	399,483	Nov 28 06:52 AM
Vitoc Vlad	Chief Executive Officer	Nov 25 '25	Buy	0.97	10,500	10,144	831,421	Nov 28 06:48 AM
Smith Stan	Director	Nov 25 '25	Buy	0.98	15,000	14,700	1,349,289	Nov 26 04:43 PM
Smith Stan	Director	Nov 24 '25	Buy	0.99	10,000	9,900	1,334,289	Nov 26 04:43 PM
Vitoc Vlad	Chief Executive Officer	Nov 24 '25	Buy	0.99	10,000	9,891	820,921	Nov 25 04:15 PM
Vitoc Vlad	Chief Executive Officer	Nov 21 '25	Buy	0.92	1,800	1,656	810,921	Nov 25 04:15 PM
Smith Stan	Director	Oct 01 '25	Buy	1.30	19,230	24,999	1,324,289	Oct 02 04:51 PM
Smith Stan	Director	Jun 03 '25	Buy	1.50	33,333	50,000	1,305,059	Jun 05 04:42 PM
Guerrero Ramiro	Director	May 08 '25	Buy	1.50	20,000	30,000	588,218	May 12 04:14 PM
Smith Stan	Director	May 08 '25	Buy	1.50	66,666	99,999	1,271,726	May 12 04:12 PM
Guerrero Ramiro	Director	Mar 03 '25	Buy	1.50	33,333	50,000	568,218	Mar 05 04:42 PM
Smith Stan	Director	Mar 03 '25	Buy	1.50	25,000	37,500	1,205,060	Mar 05 04:40 PM
Guerrero Ramiro	Director	Feb 24 '25	Buy	1.50	73,333	110,000	534,885	Feb 25 04:11 PM
Smith Stan	Director	Feb 24 '25	Buy	1.50	50,000	75,000	1,180,060	Feb 25 04:10 PM

Open in Screener

COCP

Cocrystal Pharma Inc

Feb 17 • 10:16AM ET

0.9100

-0.0549 -5.69 %

Healthcare • Biotechnology • USA • NASD

COCP Cocrystal Pharma Inc daily Stock Chart

Peers: MRNA BNTX GILD REGN PFE JNJ VRTX AZN-D NVAX SNY

| Held by: VTI VXF

Index	-	P/E	-	EPS (ttm)	-0.94	Insider Own	33.80%	Shs Outstand	13.04M	Perf Week	-4.33%
Market Cap	12.54M	Forward P/E	-	EPS next Y	-	Insider Trans	4.70%	Shs Float	9.08M	Perf Month	-18.02%
Enterprise Value	6.32M	PEG	-	EPS next Q	-	Inst Own	4.97%	Short Float	2.23%	Perf Quarter	-11.65%
Income	-9.67M	P/S	-	EPS this Y	-	Inst Trans	7.97%	Short Ratio	2.67	Perf Half Y	-46.31%
Sales	0.00M	P/B	1.55	EPS next Y	-	ROA	-72.50%	Short Interest	0.20M	Perf YTD	-7.05%
Book/sh	0.59	P/C	1.61	EPS next 5Y	-	ROE	-94.94%	52W High	2.67 -65.92%	Perf Year	-50.92%
Cash/sh	0.57	P/FCF	-	EPS past 3/5Y	-120.49% -2.62%	ROIC	-108.35%	52W Low	0.86 5.96%	Perf 3Y	-59.19%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.38% 6.20%	Perf 5Y	-96.25%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	49.10%	Oper. Margin	-	ATR (14)	0.06	Perf 10Y	-99.58%
Dividend Ex-Date	-	Quick Ratio	5.78	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	39.72	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.78	EPS Q/Q	61.60%	SMA20	-7.33%	Beta	1.20	Target Price	10.00
Payout	-	Debt/Eq	0.21	Sales Q/Q	-	SMA50	-10.51%	Rel Volume	2.40	Prev Close	0.96
Employees	11	LT Debt/Eq	0.16	Earnings	Nov 14 BMO	SMA200	-30.36%	Avg Volume	75.56K	Price	0.91
IPO	Apr 01, 2008	Option/Short	No / Yes	EPS/Sales Surpr.	11.63% -	Trades		Volume	29,429	Change	-5.69%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-08-20	Initiated	H.C. Wainwright	Buy	$5

Dec-18-25 08:00AM	Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus (GlobeNewswire)
Dec-01-25 08:00AM	Cocrystal Pharma to Present at the Noble Capital Markets' 21st Emerging Growth Equity Conference (GlobeNewswire)
Nov-14-25 08:00AM	Cocrystal Pharma Reports Third Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs (GlobeNewswire)
Oct-30-25 08:00AM	Cocrystal Pharma Insiders Purchase $1.03 Million in Private Placement Priced At-the-Market Under Nasdaq Rules (GlobeNewswire)
Oct-27-25 08:00AM	Cocrystal Pharma Receives NIH SBIR Award to Advance its Influenza Inhibitor Program (GlobeNewswire)
08:00AM	Loading…
Oct-02-25 08:00AM	Cocrystal Pharma to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference (GlobeNewswire)
Sep-15-25 04:30PM	Cocrystal Pharma, Inc. Announces Closing of Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -9.49% -7.69%
Sep-12-25 09:43AM	Cocrystal Pharma, Inc. Announces Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) +9.72%
08:00AM	Cocrystal Pharma Showcases CDI-988, the First Oral Antiviral in Development for Norovirus Infection, in a Podium Presentation at the International Calicivirus Conference (GlobeNewswire)
Sep-08-25 08:00AM	Cocrystal Pharma Receives FDA IND Clearance for Challenge Study of Oral Broad-Spectrum Protease Inhibitor CDI-988, a Potential First Antiviral for Norovirus Prevention and Treatment (GlobeNewswire)
Sep-03-25 08:00AM	Cocrystal Pharma to Participate at the H.C. Wainwright Global Investment Conference (GlobeNewswire)
Aug-14-25 08:00AM	Cocrystal Pharma Reports Second Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs (GlobeNewswire)
Aug-05-25 08:00AM	Cocrystal Pharma Presents Phase 1 Results for Pan-Viral Inhibitor CDI-988 at Department of Defense Medical Conference (GlobeNewswire) -14.95%
Jul-10-25 08:00AM	Cocrystal Pharma to Present Data from Phase 1 Study of First-in-Class Norovirus Protease Inhibitor CDI-988 at the 9th International Calicivirus Conference (GlobeNewswire)
Jun-05-25 08:00AM	Cocrystal Pharma's Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference (GlobeNewswire)
08:00AM	Loading…
May-29-25 08:00AM	Cocrystal Pharma's Investigational Drug Candidate CC-42344 Demonstrates Strong Antiviral Potency Against the 2024 Highly Pathogenic H5N1 Avian Influenza Strain (GlobeNewswire) +8.74%
May-28-25 08:00AM	Cocrystal Pharma to Participate in Noble Capital Markets' 2025 Emerging Growth Virtual Equity Conference (GlobeNewswire)
May-15-25 08:00AM	Cocrystal Pharma Reports First Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs (GlobeNewswire)
Apr-24-25 08:00AM	Cocrystal Pharma's Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants (GlobeNewswire)
Apr-16-25 08:00AM	Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference (GlobeNewswire)
Mar-31-25 08:00AM	Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs (GlobeNewswire)
Mar-14-25 08:35AM	Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing (GlobeNewswire)
Mar-12-25 01:12PM	Life Sciences Investor Forum Agenda Announced for March 13th (GlobeNewswire)
Mar-06-25 08:00AM	Cocrystal Pharma to Participate in a Fireside Chat at the Zacks SCR Life Sciences Virtual Investor Forum on March 13, 2025 (GlobeNewswire)
Jan-08-25 08:00AM	Cocrystal Pharma Reports Phase 1 Results with Oral, Broad-Acting Antiviral Drug CDI-988 for Prophylaxis and Treatment of Norovirus, Coronaviruses and Other Viral Infections (GlobeNewswire) +6.50%
Jan-02-25 06:34AM	Cocrystal to extend enrolment in Phase IIa influenza inhibitor trial (Clinical Trials Arena) +14.85%
Dec-31-24 02:03PM	Cocrystal Pharma Shares Drop 35% Following Phase 2a Study Extension Announcement (GuruFocus.com) -37.85%
08:00AM	Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study with Oral PB2 inhibitor CC-42344 (GlobeNewswire)
Nov-13-24 08:00AM	Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs (GlobeNewswire)
Oct-31-24 08:00AM	Cocrystal Pharma's Co-CEOs Highlight Pioneering Approach to Antiviral Drug Candidates Targeting Influenza and Coronaviruses as Fall Flu and COVID Season Begins (GlobeNewswire)
08:00AM	Loading…
Sep-26-24 08:00AM	Cocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor CDI-988 into Phase 1 Multiple-Ascending Dose Cohorts (GlobeNewswire)
Aug-19-24 04:05PM	Cocrystal Pharma to Highlight Near-term Clinical Milestones During Presentations at Two Upcoming Investment Conferences (GlobeNewswire) +15.38% -9.05%
Aug-15-24 03:00PM	CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event (ACCESSWIRE)
Aug-14-24 08:00AM	Cocrystal Pharma Reports Second Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs (GlobeNewswire) -10.53%
Jul-18-24 08:00AM	Cocrystal Pharma Reports Favorable Results from Single-Ascending Dose Cohorts of Phase 1 Study with CDI-988, its Oral Pan-Viral Norovirus/Coronavirus Protease Inhibitor (GlobeNewswire)
Jun-20-24 08:00AM	New Broad-Spectrum Antiviral Currently in a Phase 2a Clinical Trial in Influenza A may be Effective Against the H5N1 Avian Influenza Strain Identified in Humans Exposed to Infected Dairy Cows (GlobeNewswire)
Jun-07-24 09:55AM	Cocrystal Pharma, Inc. (COCP) Now Trades Above Golden Cross: Time to Buy? (Zacks)
May-13-24 01:53PM	COCP Stock Earnings: Cocrystal Pharma Beats EPS for Q1 2024 (InvestorPlace)
08:00AM	Cocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs (GlobeNewswire)
May-01-24 08:00AM	Enrollment Completed in Phase 2a Study with Cocrystal Pharma's Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza (GlobeNewswire)
Mar-28-24 01:53PM	COCP Stock Earnings: Cocrystal Pharma Beats EPS for Q4 2023 (InvestorPlace) -6.67%
08:00AM	Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs (GlobeNewswire)
Mar-19-24 08:00AM	Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A (GlobeNewswire)
Mar-05-24 08:30AM	Cocrystal Pharma Discusses Antiviral Therapeutics' Clinical Development and 2024 Value Catalysts in New CEO Video Interview on Planet MicroCap (ACCESSWIRE)
Jan-04-24 08:00AM	Cocrystal Pharma Provides an Update on the Clinical Development of its Novel, Broad-Spectrum Antiviral Investigational Candidates (GlobeNewswire)
Dec-06-23 08:00AM	Cocrystal Pharma Announces First-Patient-In for Phase 2a Human Challenge Study Evaluating Oral CC-42344 in Pandemic and Seasonal Influenza A (GlobeNewswire)
Nov-29-23 08:00AM	Cocrystal Pharma Highlights its Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coast (GlobeNewswire)
Nov-27-23 08:00AM	Cocrystal Pharma to Present at the NobleCon 19 Conference on December 4, 2023 (GlobeNewswire) +17.12%
Nov-13-23 08:00AM	Cocrystal Pharma Reports Third Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs (GlobeNewswire)
Nov-09-23 08:00AM	Cocrystal Pharma to Discuss Progress with Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coast (GlobeNewswire)
Oct-31-23 08:00AM	Cocrystal Pharma Receives UK MHRA Authorization to Initiate Its Phase 2a Influenza Human Challenge Trial with Oral PB2 Inhibitor CC-42344 (GlobeNewswire) +5.25%
Oct-02-23 12:14PM	COCP: Cocrystal Pharma doses 1st subjects in the important CDI-988 clinical trial. (Zacks)
Sep-28-23 08:00AM	Cocrystal Pharma Doses First Subjects in Clinical Study of CDI-988 For Pandemic Norovirus and Coronavirus (GlobeNewswire)
Sep-05-23 08:00AM	Cocrystal Pharma to Participate in the H.C. Wainwright Global Investment Conference (GlobeNewswire) -8.38%
Aug-16-23 09:11AM	COCP: Cocrystal Pharma reports 2nd quarter 2023 financial results and provides updates on drug pipeline. (Zacks)
Aug-14-23 08:00AM	Cocrystal Pharma Reports Second Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs (GlobeNewswire)
Aug-08-23 08:00AM	Cocrystal Pharma Selects Novel Oral Protease Inhibitor CDI-988 as Norovirus Lead (GlobeNewswire) +7.39%
May-31-23 08:00AM	Cocrystal Pharma Receives HREC Approval to Initiate Phase 1 Study to Evaluate Oral Broad-Spectrum Coronavirus 3CL Protease Inhibitor CDI-988 (GlobeNewswire)
May-17-23 09:26AM	COCP: Cocrystal Pharma reports 1st quarter 2023 financial results and provides updates on drug pipeline. (Zacks Small Cap Research) -5.88%
May-15-23 08:00AM	Cocrystal Pharma Reports First Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs (GlobeNewswire) -5.28%
May-04-23 04:05PM	Cocrystal Pharma Presents New Data from its CC-42344 Phase 1 Influenza A Study at the 7th Annual ISIRV Antiviral Group Conference (GlobeNewswire)
Apr-24-23 08:00AM	Cocrystal Pharma Appoints Pharma Industry Veteran Fred Hassan to its Board of Directors (GlobeNewswire) +6.05%
Apr-18-23 08:00AM	Cocrystal Pharma to Present New Data from its CC-42344 Phase 1 Influenza A Study at the 7th Annual ISIRV Antiviral Group Conference (GlobeNewswire)
Apr-10-23 08:30AM	Cocrystal Pharma Completes $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) +12.95%
Mar-31-23 10:05AM	COCP: UPDATE: Cocrystal Pharma announces full year 2022 financial results and provides drug program updates. (Zacks Small Cap Research) +5.85%
Mar-29-23 08:00AM	Cocrystal Pharma Reports 2022 Financial Results and Provides Updates on its Antiviral Drug Development Programs (GlobeNewswire)
Mar-22-23 01:03PM	COCP: UPDATE: Cocrystal Pharma announced several program updates and investor events. (Zacks Small Cap Research)
08:00AM	Cocrystal Pharma to Highlights Progress with Its Antiviral Portfolio at the Virtual Investor Summit on March 29, 2023 (GlobeNewswire)
Jan-26-23 08:00AM	Cocrystal Pharma Announces Participation in Virtual Investor Events (GlobeNewswire) -6.62%
Jan-23-23 09:00AM	Cocrystal Pharma Discusses Clinical Progress and Significance of Its Novel Antiviral Therapeutics Pipeline with The Stock Day Podcast (Newsfile)
Dec-19-22 08:00AM	Cocrystal Pharma Reports Highly Favorable Safety and Tolerability Results from a Phase 1 Study with its Oral Antiviral CC-42344 for the Treatment of Pandemic and Seasonal Influenza A (GlobeNewswire) -11.39%
Dec-01-22 04:05PM	Cocrystal Pharma Highlights Progress with CC-42344 as a Potential Oral Treatment for Pandemic and Seasonal Influenza A at the World Antiviral Congress 2022 (GlobeNewswire)
Nov-17-22 01:38PM	Cocrystal Pharma Posts Favorable Safety Data From Oral Antiviral Against Influenza A (Benzinga)
08:00AM	Cocrystal Pharma Announces Favorable Safety Data from the Phase 1 Study with Oral Antiviral CC-42344 for the Treatment of Pandemic and Seasonal Influenza A (GlobeNewswire)
Nov-15-22 11:19AM	COCP: UPDATE: Cocrystal Pharma releases 2022 3rd quarter results and provides an update on the current pipeline programs. (Zacks Small Cap Research)
Nov-14-22 08:00AM	Cocrystal Pharma Reports Third Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs (GlobeNewswire)
Nov-02-22 08:00AM	Cocrystal Pharma to Participate in Two Investor Conferences in November (GlobeNewswire) +13.41%
Nov-01-22 04:05PM	Cocrystal Pharma Granted European Patent Covering Oral Antiviral Candidate CC-42344 in Combination with Another Antiviral Agent for the Treatment of Influenza (GlobeNewswire)
Oct-26-22 08:00AM	Enrollment Completed in Phase 1 Influenza A Study with Cocrystal Pharmas Oral Antiviral Candidate CC-42344 (GlobeNewswire)
Oct-19-22 08:00AM	Cocrystal Pharma to Present at the LD Micro Main Event XV (GlobeNewswire)
Oct-13-22 08:00AM	Cocrystal Pharma to Present CC-42344 Phase 1 Influenza A Data at the World Antiviral Congress 2022 (GlobeNewswire)
Oct-11-22 11:51AM	Cocrystal Pharma Advances One Of Its COVID-19 Antiviral Treatment Candidate (Benzinga) -9.02%
08:00AM	Cocrystal Pharma Selects CDI-988 for Clinical Development as an Oral Treatment for COVID-19 (GlobeNewswire)
Oct-05-22 08:00AM	Cocrystal Pharma to Present at the Dawson James Securities 2022 Small Cap Growth Conference (GlobeNewswire)
Oct-03-22 04:05PM	Cocrystal Pharma Announces a 1-for-12 Reverse Stock Split (GlobeNewswire) -13.65%
Sep-06-22 10:05AM	Companies Like Cocrystal Pharma (NASDAQ:COCP) Are In A Position To Invest In Growth (Simply Wall St.)
08:00AM	Cocrystal Pharma to Participate in the H.C. Wainwright Global Investment Conference (GlobeNewswire)
Aug-19-22 08:10AM	COCP: UPDATE: Cocrystal Pharma releases 2022 2nd quarter results and provides an update on the current pipeline programs. (Zacks Small Cap Research) -6.42%
Aug-15-22 08:00AM	Cocrystal Pharma Reports Second Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs (GlobeNewswire)
Aug-08-22 08:00AM	Cocrystal Pharma Engages CRO to Conduct Phase 2a Human Challenge Influenza A Clinical Trial with Novel, Broad-Spectrum Antiviral Candidate CC-42344 (GlobeNewswire)
Aug-03-22 09:00AM	Cocrystal Pharma Discusses Therapeutic Platform Applications and Progress with The Stock Day Podcast (Newsfile)
Jul-14-22 08:00AM	Cocrystal Pharma Reports CC-42344 Pharmacokinetic Data in Influenza A Once-Daily Dosing (GlobeNewswire)
Jun-01-22 08:00AM	Cocrystal Pharma Expands Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate COVID-19 Protease Inhibitors (GlobeNewswire)
May-18-22 08:00AM	Cocrystal Pharma to Present at the H.C. Wainwright Global Investment Conference (GlobeNewswire)
May-12-22 08:12AM	COCP: Cocrystal Pharma Releases 2022 1st Quarter Results and Provides an Update on the Current Pipeline Programs (Zacks Small Cap Research)
May-11-22 08:00AM	Cocrystal Pharma Reports First Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs and Milestones (GlobeNewswire) -5.02%
Apr-21-22 08:00AM	Cocrystal Pharma Collaborates with the National Institute of Allergy and Infectious Diseases to Evaluate COVID-19 Protease Inhibitors (GlobeNewswire)
Apr-19-22 08:00AM	Cocrystal Pharma to Present at the Life Science Innovation Northwest 2022 Conference (GlobeNewswire)
Apr-14-22 08:00AM	Cocrystal Pharma to Present at the Noble Capital Markets NobleCon18 Conference (GlobeNewswire)
Apr-12-22 11:01AM	Cocrystal Pharma Posts Favorable Preliminary Data From Influenza A Antiviral Candidate Trial (Benzinga)

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses. Cocrystal employs unique structure-based technologies to create first- and best-in-class antiviral drugs. The company was founded in 2008 and is headquartered in Bothell, WA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FROST PHILLIP MD ET AL	Director	Feb 06 '26	Buy	0.95	50,000	47,280	1,888,551	Feb 09 04:10 PM
FROST PHILLIP MD ET AL	Director	Dec 31 '25	Buy	0.95	50,000	47,275	1,838,551	Jan 02 04:10 PM
FROST PHILLIP MD ET AL	Director	Dec 30 '25	Buy	0.97	20,000	19,310	1,788,551	Dec 31 04:10 PM
FROST PHILLIP MD ET AL	Director	Dec 26 '25	Buy	0.97	40,000	38,944	1,768,551	Dec 29 09:24 AM
FROST PHILLIP MD ET AL	Director	Dec 24 '25	Buy	0.97	25,000	24,258	1,728,551	Dec 29 09:24 AM
FROST PHILLIP MD ET AL	Director	Nov 26 '25	Buy	0.99	4,000	3,975	1,703,551	Nov 28 09:00 AM
FROST PHILLIP MD ET AL	Director	Nov 25 '25	Buy	0.94	20,000	18,812	1,699,551	Nov 25 08:17 PM

Open in Screener

BLNE

Beeline Holdings Inc

Feb 17 • 10:18AM ET

2.98

-0.05 -1.49 %

Financial • Mortgage Finance • USA • NASD

BLNE Beeline Holdings Inc daily Stock Chart

Peers: DEO BUD STZ TAP SAM BF-A BF-B MO KDP SBEV

| Held by: VXF

Index	-	P/E	-	EPS (ttm)	-27.85	Insider Own	19.09%	Shs Outstand	27.75M	Perf Week	-4.63%
Market Cap	82.85M	Forward P/E	-	EPS next Y	-0.12	Insider Trans	1.30%	Shs Float	22.46M	Perf Month	8.15%
Enterprise Value	91.05M	PEG	-	EPS next Q	-0.31	Inst Own	17.25%	Short Float	5.27%	Perf Quarter	71.55%
Income	-6.46M	P/S	10.46	EPS this Y	82.67%	Inst Trans	22.05%	Short Ratio	1.22	Perf Half Y	83.13%
Sales	7.92M	P/B	1.14	EPS next Y	97.27%	ROA	-13.88%	Short Interest	1.18M	Perf YTD	73.55%
Book/sh	2.62	P/C	61.83	EPS next 5Y	-	ROE	-23.93%	52W High	8.40 -64.46%	Perf Year	-53.79%
Cash/sh	0.05	P/FCF	-	EPS past 3/5Y	27.53% 40.57%	ROIC	-12.26%	52W Low	0.62 381.30%	Perf 3Y	-94.97%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-32.74% -20.16%	Gross Margin	4.07%	Volatility	10.65% 14.00%	Perf 5Y	-99.32%
Dividend TTM	-	EV/Sales	11.50	EPS Y/Y TTM	61.45%	Oper. Margin	-91.07%	ATR (14)	0.33	Perf 10Y	-99.88%
Dividend Ex-Date	-	Quick Ratio	1.05	Sales Y/Y TTM	-24.58%	Profit Margin	-81.57%	RSI (14)	51.24	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.05	EPS Q/Q	97.91%	SMA20	-7.32%	Beta	1.60	Target Price	4.50
Payout	-	Debt/Eq	0.18	Sales Q/Q	208.42%	SMA50	18.00%	Rel Volume	0.65	Prev Close	3.03
Employees	76	LT Debt/Eq	0.02	Earnings	Nov 06 BMO	SMA200	39.04%	Avg Volume	974.70K	Price	2.98
IPO	Apr 16, 2014	Option/Short	No / Yes	EPS/Sales Surpr.	20.83% 6.83%	Trades		Volume	105,991	Change	-1.49%

Feb-04-26 08:46AM	Beeline Holdings to integrate BLINKQC into Encompass platform (TipRanks)
Feb-03-26 03:30PM	Beeline Holdings (BLNE) to Integrate BLINKQC Into Encompass Loan Origination System (NewMediaWire) +7.38%
08:30AM	Beeline to Integrate Its Digital Quality Control Platform, BLINKQC, Into Encompass Platform, Expanding Access to Over 3,100 Mortgage Lenders (GlobeNewswire)
Jan-30-26 03:00PM	Beeline Holdings (BLNE) Schedules Q4 2025 Stakeholder Update Call (NewMediaWire) -8.46%
Jan-29-26 04:35PM	Beeline to Host Stakeholder Update Call on Q4 2025 Financial Results (GlobeNewswire)
03:00PM	Loading…
Jan-21-26 03:00PM	Beeline Holdings (BLNE) CEO Details 2025 Milestones, Strategic Priorities (NewMediaWire)
Jan-15-26 08:30AM	Beeline CEO Publishes Letter to Shareholders (GlobeNewswire) +17.95%
Jan-13-26 03:30PM	Beeline Holdings (BLNE) Sees Potential Mortgage Activity Upside From $200B MBS Purchase Plan (NewMediaWire)
08:30AM	Beeline Commends President Trump's Announcement of $200 Billion Agency MBS Purchase (GlobeNewswire)
Dec-17-25 03:30PM	Beeline Holdings (BLNE) Targets Faster, Simpler Mortgages as It Expands AI-Driven Lending Model (NewMediaWire)
Dec-15-25 02:30PM	Profit Momentum Builds for Beeline Holdings (BLNE) as Next-Gen Platform Accelerates (NewMediaWire)
Dec-05-25 03:30PM	Beeline Holdings (BLNE) Aims to Close Homeownership Gap With Cutting-Edge Platform (NewMediaWire)
Nov-25-25 02:30PM	Beeline Holdings (BLNE) Reports 37% Revenue Growth, Lower Expenses as Digital Mortgage Momentum Builds (NewMediaWire)
Nov-24-25 02:30PM	Beeline Holdings (BLNE) Reaches Cash-Flow Milestone as Growth Strategy Gains Traction (NewMediaWire) +13.82%
Nov-18-25 02:30PM	Beeline Holdings (BLNE) Closes $7.4M Registered Direct as Company Targets Cash Flow Positive in Q1 2026 (NewMediaWire) -6.51%
10:59AM	Loading…
Nov-17-25 10:59AM	Beeline Clarifies Recent Fundraising (GlobeNewswire)
Nov-12-25 03:00PM	Beeline Holdings (BLNE) Achieves Cash Flow Positivity in Lending Operations, Prices $7.4M Registered Direct Offering (NewMediaWire)
Nov-11-25 09:00AM	Beeline's Lending Entity Achieves Cash Flow Positive Month in October (GlobeNewswire) -16.11%
12:03AM	Beeline Holdings Inc (BLNE) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... (GuruFocus.com)
Nov-06-25 03:00PM	Beeline Holdings (BLNE) Reports 35% Sequential Growth in Q3 Originations and 37% Revenue Increase (NewMediaWire) -10.41%
09:00AM	Beeline Reports 37% Q3 2025 Revenue Growth, 9% Expense Reduction and Zero Debt Following Strategic Divestures (GlobeNewswire)
Oct-30-25 03:30PM	Beeline Holdings (BLNE) Sets Record Loan Volume Following Fed Rate Cut Announcement (NewMediaWire)
09:10AM	Beeline Has a Record Lock Day on The Federal Reserve's Announcement of a 25-Basis-Point Rate Cut (GlobeNewswire)
Oct-27-25 08:20AM	Beeline Launches Nation's First Blockchain-Powered Home Equity Platform - Begins Scaling Nationwide (GlobeNewswire)
08:00AM	EXCLUSIVE: Beeline's New Tokenized Equity Model Offers Homeowners Debt-Free Liquidity (Benzinga)
Oct-24-25 04:30PM	Beeline to Host Stakeholder Update Call on Q3 2025 Financial Results (Newsfile) +5.70%
Oct-16-25 03:30PM	Beeline Holdings (BLNE) Expands Warehouse Lending Capacity to $25M to Support Rapid Growth (NewMediaWire) -6.87%
09:00AM	Beeline Expands Warehouse Capacity to $25 Million, Adds Two New Banking Partners to Fuel Accelerating Growth (GlobeNewswire)
Oct-08-25 02:00PM	Beeline Holdings (BLNE) CEO Nick Liuzza on Latest TechMediaWire Podcast Episode (NewMediaWire)
Oct-07-25 02:30PM	Beeline Holdings (BLNE) Bullish About Millennials and Gen Z Lendable Market; Floats AI-Powered Mortgage and Loans Product (NewMediaWire) -7.61%
02:30PM	Loading…
Oct-03-25 02:30PM	Beeline Holdings (BLNE) Clears Debt and Boosts Revenue, On Track to Becoming Cash Flow Positive by Early 2026 (NewMediaWire) -5.90%
Sep-30-25 03:00PM	Beeline Holdings (BLNE) CEO Highlights AI-Powered Mortgage Platform in Benzinga Podcast (NewMediaWire)
08:30AM	IBN Announces Beeline Holdings Inc. CEO Nick Liuzza Featured in Exclusive Benzinga Podcast Interview Highlighting Beeline's AI-powered, Digital Mortgage Platform (GlobeNewswire)
Sep-23-25 02:30PM	Beeline Holdings (BLNE) Uses AI-Age Tech to Ease Mortgage Origination Amid Optimism in Home Market Forecasts (NewMediaWire) -11.22%
Sep-22-25 03:30PM	Beeline Holdings (BLNE) to Present at Centurion One Capital Bahamas Summit (NewMediaWire)
Sep-19-25 01:30PM	Beeline Holdings (BLNE) Clears Debt, Targets Full Profitability by Q1 2026 (NewMediaWire) +18.44%
Sep-18-25 10:00AM	Beeline to Present at the Centurion One Capital 3rd Annual Bahamas Summit (Newsfile)
Sep-08-25 03:31PM	Beeline Holdings (BLNE) to Present at Centurion One Capital Summit in Bahamas (NewMediaWire) +11.49%
Sep-05-25 02:30PM	Beeline Holdings (NASDAQ: BLNE) Insider Buying Led by COO's 100,000-Share Purchase (NewMediaWire) +23.04%
10:14AM	Beeline to Present at Centurion One Capital Summit in the Bahamas as Insider Buying Accelerates (GlobeNewswire)
Sep-04-25 10:23AM	Beeline Eliminates $7 Million in Debt, Positioned for Cash Flow Positive Operations by Q1 2026 (GlobeNewswire) +18.63%
Sep-03-25 02:30PM	Beeline Holdings (BLNE) Reports Strong Q2/25 Results, Targets Profitability in Early 2026 (NewMediaWire)
Aug-29-25 03:30PM	Beeline Holdings (NASDAQ: BLNE) Outlines Milestones Achieved and Strategic Initiatives Driving 2026 Outlook (NewMediaWire) -8.14%
Aug-28-25 08:30AM	Beeline Provides Letter to Shareholders (Newsfile) +11.69%
Aug-27-25 03:30PM	Beeline Holdings (NASDAQ: BLNE) Expands AI Agent Bob Into Sales and Origination After Strong Q2 Pilot Results (NewMediaWire) +5.48%
09:00AM	Beeline Expands AI Agent 'Bob' into Sales, Driving $7.1M in Q2 Originations (Newsfile)
08:31AM	EXCLUSIVE: Beeline Expands AI Agent Bob Beyond Support To Drive Mortgage Sales, Origination Growth (Benzinga)
Aug-21-25 08:30AM	Beeline Expands AI Strategy with Additional Investment in MagicBlocks to Drive Revenue Growth and Global SaaS Opportunity (Newsfile)
Aug-15-25 03:24AM	Beeline Holdings Inc (BLNE) Q2 2025 Earnings Call Highlights: Strategic Divestment and Revenue ... (GuruFocus.com) -26.58%
Aug-14-25 04:05PM	Beeline Holdings Reports Q2 2025 Results: Highlights Include Improved Revenue, Reduced Debt and Significant Cash on Hand (Newsfile) +10.45%
Jul-29-25 08:30AM	Beeline Completes Strategic Divestiture to Accelerate Digital Mortgage, Title, and Equity Product Expansion (Newsfile) -7.01%
Jul-18-25 05:00PM	Beeline to Announce Q2 2025 Financial Results and Host Stakeholder Update Call (Newsfile) +10.64% +6.41%
Jul-15-25 08:00AM	Beeline Assigns Kristin Miller to Lead BlinkQC as the Product Moves from Beta to Production (Newsfile)
Jul-01-25 02:30PM	IBN Coverage: Beeline Holdings (NASDAQ: BLNE) Raises $6.5M, Slashes Debt to Strengthen Financial Position (NewMediaWire) -8.78%
08:30AM	Beeline Strengthens Balance Sheet in June with $6.5M Capital Raise and Major Debt Reduction (GlobeNewswire)
Jun-25-25 08:40AM	Beeline Title Among the First to Close Crypto Real Estate Transaction (GlobeNewswire) -7.04%
08:30AM	Beeline Title Closes its First Crypto Real Estate Transaction - Building a Title Platform for Lenders leveraging Stable Coins looking to infuse liquidity in Residential Real Estate (GlobeNewswire)
08:00AM	EXCLUSIVE: Beeline Closes Its First Crypto Real Estate Transaction (Benzinga)
Jun-24-25 03:00PM	IBN Coverage: Beeline Holdings (NASDAQ: BLNE) Surpasses $1 Billion in Loans as AI Mortgage Platform Scales Nationwide (NewMediaWire) +29.09%
Jun-12-25 05:05PM	Beeline to Unlock Real Estate Liquidity for Consumers through a Stablecoin Funding (Newsfile)
Jun-04-25 08:30AM	Beeline Taps Crypto Ecosystem to Unlock Real Estate Liquidity for Consumers Through a Stablecoin Funding (Newsfile)
May-29-25 08:30AM	Beeline Unveils One-Click AI Sales Agent - Transforming Website Traffic into Mortgage Leads in Under Two Minutes (GlobeNewswire)
May-21-25 08:15AM	Beeline Holdings Reports Q1 2025 Results: First Quarter as Public Company Highlights AI-Led Growth, Record Originations, and Transformational Fintech Expansion (GlobeNewswire) -7.20%
03:04AM	Beeline Holdings Inc (BLNE) Q1 2025 Earnings Call Highlights: Revenue Surge Amid Strategic ... (GuruFocus.com)
May-20-25 04:15PM	Beeline Holdings Reports Q1 2025 Results: First Quarter as Public Company Highlights AI-Led Growth, Record Originations, and Transformational Fintech Expansion (Newsfile)
May-16-25 12:51PM	Beeline to Announce Q1 2025 Financial Results and Host Stakeholder Update Call (Newsfile)
May-15-25 08:30AM	Beeline Appoints Veteran Public Company Executive Frank Knuettel II to Board of Directors (GlobeNewswire)
May-08-25 09:00AM	Beeline's New Affiliate Network to Target 200,000 Realtors and Creators, Accelerate Real Estate Investor Lending (GlobeNewswire)
Apr-29-25 09:00AM	Beeline Hits $1 Billion in Originations, Driving the Future of Digital Mortgage Lending (GlobeNewswire)
Apr-28-25 08:30AM	Beeline teams up with Rabbu to make finding and funding short term rental properties frictionless (GlobeNewswire) +6.99%
Apr-24-25 08:30AM	Beeline CEO and COO to Present at Ladenburg Thalmann Technology Innovation Expo on May 21 in New York City (GlobeNewswire) +8.96%
Apr-15-25 04:15PM	Beeline Holdings Reports Full Year 2024 Results and Provides Business Update (Newsfile) -15.25%
Apr-08-25 04:50AM	Beeline Accelerates Growth Rate in 2024 with Just Under $200M in Originations - Outpacing Industry by 29% (Newsfile) -9.70%
Apr-03-25 09:48AM	Beeline to Release Year-End Results and Invites Stakeholders to Business Update Call (Newsfile)
Mar-26-25 12:42PM	Beeline CEO Invests Another $900,000 in Series G Offering Priced at a 205% Premium to Market Price and Donates Warrants to St. Jude Children's Research Hospital (Newsfile) +10.64%
Mar-25-25 08:30AM	Beeline CEO Invests an Additional $900,000 in Series G Offering Priced at a 205% Premium to Market Price and Donates Warrants to St. Jude Children's Research Hospital (Newsfile) +12.57%
Mar-20-25 08:30AM	Beeline Announces Public Launch of MagicBlocks, an AI-Powered Sales Agent Platform (Newsfile)
Mar-19-25 08:30AM	RETRANSMISSION: Beeline Board of Directors Approves Waiver of Insider Trading Policy (Newsfile) -16.21%
Mar-18-25 05:50PM	Beeline Board of Directors Approves Waiver of Insider Trading Policy (Newsfile) -5.23%
09:00AM	Beeline's AI Sales Agent 'Bob 2.0' Delivers 6X More Leads than Human Chat - Revolutionizing Mortgage Sales at Near Zero Cost (Newsfile)
Mar-12-25 08:30AM	Beeline Holdings Appoints Industry Veteran David Kittle as Special Advisor (Newsfile) -7.65%
Mar-10-25 07:30AM	Beeline Holdings Receives Nasdaq Approval as a New Listing (Newsfile) -10.53%
Feb-26-25 08:30AM	Beeline and CredEvolv Partner to Expand Disruptive Mortgage Platform (Newsfile)
Feb-19-25 08:30AM	Beeline Secures $5M Funding as CEO Invests $2.9M to Drive AI Mortgage Disruption (Newsfile) +10.86%
Feb-12-25 08:30AM	Beeline Loans and RedAwning Partner to Revolutionize Real Estate Investing (Newsfile)
Feb-06-25 08:15AM	Beeline Labs Announces First Capital Raise for Cutting-Edge AI Sales Solution in Magic Blocks (Newsfile)
Jan-30-25 09:00AM	Beeline Launches 'Beeline Labs' to Drive Revenue Growth with Groundbreaking SaaS Model and BlinkQC (Newsfile)
Jan-28-25 08:30AM	Beeline Holdings Reports Results of Special Shareholder Meeting Held on Monday, January 27, 2025 (Newsfile) -12.63%
Jan-23-25 08:30AM	Eastside Distilling, Inc. Launches AI Based Online Mortgage Business Beeline Financial Holdings, Inc. and Commencement of Trading Under New Ticker Symbol 'BLNE' (Newsfile) +15.66%
Jan-21-25 10:55AM	Eastside Distilling Announces Postponement of Special Meeting of Stockholders (Newsfile) +6.27%
Jan-17-25 09:25AM	Eastside Distilling Unveils Strategic Partnerships to Boost Production and Expand Marketing in 2025 (PR Newswire) -5.16%
Nov-15-24 08:00AM	Eastside Distilling, Inc. Announces Private Placement Offering (PR Newswire)
Nov-14-24 04:10PM	Eastside Distilling Reports Third Quarter 2024 Financial Results (PR Newswire)
Nov-06-24 05:22PM	Eastside Distilling, Inc. Provides Update on its Merger with Beeline Financial Holdings, Inc. (PR Newswire)
Nov-05-24 06:12PM	Eastside Distilling, Inc. to Report 2024 Third Quarter Results on Thursday, November 14, 2024 (PR Newswire) -5.87%
Oct-10-24 08:00AM	Eastside Distilling, Inc. Announces Closing of its Merger with AI Powered Beeline Financial Holdings, Inc. (PR Newswire)
Oct-08-24 05:50PM	Eastside Distilling Announces Corporate Transformation and Debt Restructuring (TipRanks) -5.03%
Sep-11-24 06:00PM	Eastside Distilling, Inc. to Merge with Beeline Financial Holdings, Inc (PR Newswire) -19.71%
Sep-06-24 04:45PM	Eastside Distilling Announces Closing of $0.4 Million Registered Direct Offering, Priced at a Premium to Market Under Nasdaq Rules (PR Newswire) -20.42%
Sep-05-24 03:30PM	Eastside Distilling Announces $0.4 Million Registered Direct Offering, Priced at a Premium to Market Under Nasdaq Rules (PR Newswire) +89.45%

Beeline Holdings, Inc. operates as a mortgage technology company. It also offers handcrafted spirits and digital printing can through its subsidiary. It operates through the following segments: Beeline, Bridgetown Spirits, and Corporate. The company was founded by Lenny Gotter in 2004 and is headquartered in Providence, RI.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Freedman Joseph David	Director	Nov 26 '25	Buy	1.85	1,000	1,850	364,891	Nov 28 09:00 AM
Moe Christopher R.	Chief Financial Officer	Nov 19 '25	Buy	1.68	20,000	33,600	40,000	Nov 19 04:38 PM
Freedman Joseph David	Director	Nov 19 '25	Buy	1.62	7,000	11,340	360,891	Nov 19 04:01 PM
Freedman Joseph David	Director	Sep 25 '25	Buy	4.22	10,000	42,193	165,920	Sep 29 09:45 PM
Moe Christopher R.	Chief Financial Officer	Sep 03 '25	Buy	1.64	20,000	32,822	20,000	Sep 04 01:42 PM
Milton Tiffany	Chief Accounting Officer	Sep 03 '25	Buy	1.59	10,000	15,900	10,003	Sep 03 04:10 PM
Freedman Joseph David	Director	Jun 16 '25	Buy	0.69	35,000	24,013	140,920	Jun 17 01:50 PM
Freedman Joseph David	Director	Jun 17 '25	Buy	0.67	15,000	10,017	155,920	Jun 17 01:50 PM
Liuzza Nicholas Reyland JR	Chief Executive Officer	Jun 13 '25	Buy	0.66	113,500	74,914	1,881,548	Jun 16 04:05 PM
Liuzza Nicholas Reyland JR	Chief Executive Officer	May 21 '25	Buy	1.17	27,304	32,011	1,767,048	May 23 03:12 PM
Liuzza Nicholas Reyland JR	Chief Executive Officer	May 22 '25	Buy	1.16	1,000	1,160	1,768,048	May 23 03:12 PM
Liuzza Nicholas Reyland JR	Chief Executive Officer	May 16 '25	Buy	1.26	9,900	12,502	1,739,744	May 19 04:01 PM
Liuzza Nicholas Reyland JR	Chief Executive Officer	May 15 '25	Buy	1.30	700	909	1,729,844	May 19 04:01 PM
Liuzza Nicholas Reyland JR	Chief Executive Officer	May 07 '25	Buy	1.38	1,450	2,008	1,727,836	May 09 04:05 PM
Liuzza Nicholas Reyland JR	Chief Executive Officer	May 08 '25	Buy	1.47	1,308	1,921	1,729,144	May 09 04:05 PM
Liuzza Nicholas Reyland JR	Chief Executive Officer	May 05 '25	Buy	1.44	5,093	7,325	1,726,386	May 06 04:31 PM
Liuzza Nicholas Reyland JR	Chief Executive Officer	May 02 '25	Buy	1.39	18,200	25,248	1,721,293	May 02 09:50 PM
Liuzza Nicholas Reyland JR	Chief Executive Officer	May 01 '25	Buy	1.43	10,082	14,453	1,703,093	May 02 10:41 AM
Liuzza Nicholas Reyland JR	Chief Executive Officer	Apr 30 '25	Buy	1.49	4,450	6,613	1,693,011	May 02 10:41 AM
Liuzza Nicholas Reyland JR	Chief Executive Officer	Apr 29 '25	Buy	1.34	3,395	4,533	1,688,561	May 02 10:39 AM
Liuzza Nicholas Reyland JR	Chief Executive Officer	Apr 25 '25	Buy	1.46	3,450	5,027	1,685,166	Apr 28 04:45 PM
Liuzza Nicholas Reyland JR	Chief Executive Officer	Apr 23 '25	Buy	1.37	3,700	5,051	1,682,416	Apr 25 04:05 PM
Liuzza Nicholas Reyland JR	Chief Executive Officer	Apr 22 '25	Buy	1.27	3,910	4,959	1,678,716	Apr 24 08:00 AM
Freedman Joseph David	Director	Apr 16 '25	Buy	1.17	15,251	17,891	101,161	Apr 17 04:38 PM
Freedman Joseph David	Director	Apr 17 '25	Buy	1.15	4,749	5,439	105,910	Apr 17 04:38 PM
Liuzza Nicholas Reyland JR	Chief Executive Officer	Apr 16 '25	Buy	1.16	18,000	20,849	223,716	Apr 17 04:05 PM
Liuzza Nicholas Reyland JR	Chief Executive Officer	Mar 20 '25	Buy	2.66	23,500	62,403	1,674,806	Mar 24 04:05 PM
Liuzza Nicholas Reyland JR	Chief Executive Officer	Mar 20 '25	Buy	2.33	2,500	5,829	205,716	Mar 24 04:05 PM
Liuzza Nicholas Reyland JR	Chief Executive Officer	Mar 19 '25	Buy	2.76	16,000	44,136	203,216	Mar 20 04:06 PM
Liuzza Nicholas Reyland JR	Chief Executive Officer	Mar 19 '25	Buy	2.82	1,150	3,245	1,651,306	Mar 20 04:06 PM
Freedman Joseph David	Director	Mar 18 '25	Buy	2.84	6,250	17,732	83,910	Mar 20 04:05 PM
Freedman Joseph David	Director	Mar 19 '25	Buy	2.47	2,000	4,945	85,910	Mar 20 04:05 PM

NRDY

DMLP

GLSI

GCTS

ICCC

MAIA

COCP

BLNE

Upgrade your FINVIZ experience